Cookie Consent by Free Privacy Policy Generator

Vax Facts — Endnotes:

  1. Thomas MD, Paul, and Jennifer Margulis PhD. 2016. The Vaccine-Friendly Plan: Dr. Paul's Safe and Effective Approach to Immunity and Health—From Pregnancy Through Your Child's Teen Years. New York: Ballantine Books.
  2. Centers for Disease Control and Prevention. 2024. "Recommended Child and Adolescent Immunization Schedule for Ages 18 Years or Younger, United States 2024." cdc.gov. https://www.cdc.gov/vaccines/schedules/hcp/imz/child-adolescent.html
  3. Lyons-Weiler, James, and Paul Thomas. 2020. "Relative Incidence of Office Visits and Cumulative Rates of Billed Diagnoses along the Axis of Vaccination." International Journal of Environmental Research and Public Health 17 (22): 8674. https://doi.org/10.3390/ijerph17228674
  4. Offit, Paul. 2017. "The Unhealthiest State in America Has the Best Vaccination Rate." Daily Beast, December 15. https://www.thedailybeast.com/the-unhealthiest-state-in-america-has-the-best-vaccination-rate
    1. "ICAN's Monumental Mississippi Win Legal Update." Informed Consent Action Network. April 21. https://icandecide.org/press-release/icans-monumental-mississippi-win/
  6. Centers for Disease Control and Prevention. 2023. "Vaccine Information Statements (VISs)—Current VISs." cdc.gov. December 7. https://www.cdc.gov/vaccines/hcp/vis/current-vis.html
  7. Centers for Disease Control and Prevention. 2009. "Healthcare Professionals / Providers—Q&As about Monovalent M-M-R Vaccines." October 26. https://www.cdc.gov/vaccines/hcp/clinical-resources/mmr-faq-12-17-08.html
  8. Edwards MD, Kathryn M., and Jesse M. Hackell MD. 2016. "Countering Vaccine Hesitancy—Guidance for the Clinician in Rendering Pediatric Care." Pediatrics (The American Academy of Pediatrics) 138 (3). https://doi.org/10.1542/peds.2016-2146
    1. The Control Group. https://www.thecontrolgroup.org/
  10. Stoner, Alexis M., Sarah E. Anderson, and Timothy J. Buckley. 2013. "Ambient Air Toxics and Asthma Prevalence among a Representative Sample of US Kindergarten-Age Children." PLoS One 8 (9). https://doi.org/10.1371/journal.pone.0075176
  11. Jackson, Kristen D., LaJeana D. Howie, and Lara J. Akinbami. 2013. "Trends in Allergic Conditions among Children: United States, 1997–2011." NCHS Data Brief (121): 1–8. https://pubmed.ncbi.nlm.nih.gov/23742874/
  12. Food Allergy Research & Education. 2017. "FAIR Health Reports That Food Allergy Prevalence, Treatment and Costs Have Skyrocketed in Past Decade." FARE. November 22. https://www.foodallergy.org/media-room/fair-health-reports-food-allergy-prevalence-treatment-and-costs-have-skyrocketed-past
  13. Zablotsky, Benjamin, Lindsey I. Black, and Stephen J. Blumberg. 2017. "Estimated Prevalence of Children with Diagnosed Developmental Disabilities in the United States, 2014–2016." NCHS Data Brief (291): 1–8. https://pubmed.ncbi.nlm.nih.gov/29235982/
  14. Rowland, Andrew S., Betty J. Skipper, and Dale P. Sandler. 2015. "The Prevalence of ADHD in a Population-Based Sample." Journal of Attention Disorders 19 (9): 741–754. https://doi.org/10.1177%2F1087054713513799
  15. Dabelea, Dana, Elizabeth J. Mayer-Davis, Sharon Saydah, Giuseppina Imperatore, Barbara Linder, Jasmin Divers, Ronny Bell, et al. 2014. "Prevalence of Type 1 and Type 2 Diabetes among Children and Adolescents from 2001 to 2009." JAMA 311 (17): 1778–1786. https://doi.org/10.1001%2Fjama.2014.3201
  16. Cunningham, Solveig A., Ashlesha Datar, K.M. Venkat Narayan, and Michael R. Kramer. 2017. "Entrenched Obesity in Childhood: Findings from a National Cohort Study." Annals of Epidemiology 27 (7): 435–441. https://doi.org/10.1016/j.annepidem.2017.05.016
  17. Kelly, Adams M., Martin Kohlmeier, and Steven Zeisel. 2010. "Nutrition Education in U.S. Medical Schools: Latest Update of a National Survey." Academic Medicine 85 (9): 1537–1542. https://doi.org/10.1097/acm.0b013e3181eab71b
  18. Humphries MD, Suzanne, and Roman Bystrianyk. 2013. Dissolving Illusions: Disease, Vaccines, and the Forgotten History. CreateSpace Independent Publishing Platform.
  19. Wakefield, Andrew J., S. H. Murch, A. Anthony, J. Linnell, D. M. Casson, M. Malik, M. Berelowitz, et al. 1998. "Ileal-lymphoid-nodular Hyperplasia, Non-specific Colitis, and Pervasive Developmental Disorder in Children." The Lancet 351 (9103): 637–641. https://doi.org/10.1016/S0140-6736(97)11096-0
  20. Sharav, Vera. 2023. "L'affaire Wakefield: Shades of Dreyfus & BMJ's Descent into Tabloid Science." Alliance for Human Research Protection (AHRP). October 30. https://ahrp.org/laffaire-wakefield-introduction/
  21. Autism Research Institute. 2024. https://autism.org/
  22. Kirby, David. 2006. Evidence of Harm: Mercury in Vaccines and the Autism Epidemic: A Medical Controversy. St. Martin's Griffin.
  23. Olmstead, Susan C. 2022. "Chronic Disease Among Kids 'Skyrocketing,' Pediatrician Tells RFK Jr." The Defender, June 22. https://childrenshealthdefense.org/defender/chronic-disease-kids-pediatrician-dr-joel-gator-warsh-rfk-jr-podcast/
  24. Shoenfeld, Yehuda, Nancy Agmon-Levin, and Lucija Tomljenovic. 2015. Vaccines and Autoimmunity. Wiley-Blackwell.
  25. Hooker, Brian S. Winter 2018. "Reanalysis of CDC Data on Autism Incidence and Time of First MMR Vaccination." Journal of American Physicians and Surgeons 23 (4): 105–109. https://www.jpands.org/vol23no4/hooker.pdf
  26. Lyons-Weiler, James, and Paul Thomas. 2020. "Relative Incidence of Office Visits and Cumulative Rates of Billed Diagnoses along the Axis of Vaccination." International Journal of Environmental Research and Public Health 17 (22): 8674. https://doi.org/10.3390/ijerph17228674
  27. Hammond, Jeremy R. 2021. The War on Informed Consent: The Persecution of Dr. Paul Thomas by the Oregon Medical Board. Skyhorse Publishing. https://www.jeremyrhammond.com/product/the-war-on-informed-consent/
  28. Lyons-Weiler, James, and Russell L. Blaylock. 2022. "Revisiting Excess Diagnoses of Illnesses and Conditions in Children Whose Parents Provided Informed Permission to Vaccinate Them." International Journal of Vaccine Theory, Practice, and Research 2 (2): 603–618. http://dx.doi.org/10.56098/ijvtpr.v2i2.59
    1. "Bruesewitz v. Wyeth LLC, 562 U.S. 223 (2011)." JUSTIA U.S. Supreme Court. February 22. https://supreme.justia.com/cases/federal/us/562/223/
    1. "VAERS COVID Vaccine Adverse Event Reports." OpenVAERS. https://openvaers.com/covid-data
  31. Kory, Pierre, and Jenna McCarthy. 2023. The War on Ivermectin: The Medicine That Saved Millions and Could Have Ended the Pandemic. Skyhorse Publishing.
  32. Ioannidis, John P.A. 2021. "Infection Fatality Rate of COVID-19 Inferred from Seroprevalence Data." Bulletin of the World Health Organization 99 (1): 19–33. https://doi.org/10.2471%2FBLT.20.265892
  33. Clark, Ross. 2020. "Stanford Study Suggests Coronavirus Might Not Be as Deadly as Flu." The Spectator, May 20. https://www.spectator.co.uk/article/stanford-study-suggests-coronavirus-might-not-be-as-deadly-as-flu/
    1. "Ex-Health Ministry Chief: 'You're Not More at Risk of Dying of Coronavirus Than the Flu'." Israel National News. May 26. https://www.israelnationalnews.com/news/280874
  35. Levin, Andrew T., William P. Hanage, Nana Owusu-Boaitey, Kensington B. Cochran, Seamus P. Walsh, and Gideon Meyerowitz-Katz. 2020. "Assessing the Age Specificity of Infection Fatality Rates for COVID-19: Systematic Review, Meta-analysis, and Public Policy Implications." European Journal of Epidemiology 35: 1123–1138. https://doi.org/10.1007%2Fs10654-020-00698-1
    1. "DoD COVID-19 Vaccine Distribution." U.S. Department of Defense. December 9. https://media.defense.gov/2020/Dec/09/2002548827/-1/-1/0/DOD-COVID-19-VACCINE-DISTRIBUTION-PLAN-AND-POPULATION-SCHEMA.PDF
  37. Kennedy Jr., Robert F. 2023. The Wuhan Cover-Up: And the Terrifying Bioweapons Arms Race. Skyhorse Publishing.
  38. Miller, Mark Crispin. 2024. "News from Underground (NFU)." Mark Crispin Miller on Substack. https://substack.com/@markcrispinmiller1
  39. McCullough, Peter. 2023. "The Global mRNA Patent Frenzy." Courageous Discourse™ on Substack. August 22. https://petermcculloughmd.substack.com/p/the-global-mrna-patent-frenzy
  40. Kennedy Jr., Robert F. 2021. The Real Anthony Fauci: Bill Gates, Big Pharma, and the Global War on Democracy and Public Health. Skyhorse Publishing.
  41. Leake, John, Peter A. McCullough, and Robert F. Kennedy Jr. 2022. The Courage to Face COVID-19: Preventing Hospitalization and Death While Battling the Bio-Pharmaceutical Complex. Skyhorse Publishing.
  42. Mercola, Dr. Joseph, and Ronnie Cummins. 2021. The Truth about COVID-19: Exposing the Great Reset, Lockdowns, Vaccine Passports, and the New Normal. Chelsea Green Publishing.
    1. CHD.TV. https://live.childrenshealthdefense.org/chd-tv/
    1. The Defender. https://childrenshealthdefense.org/defender/
    1. The Highwire. https://thehighwire.com/
  46. Thomas, Dr. Paul, and DeeDee Hoover. 2024. "Kids First 4 Ever: Dr Paul and DeeDee." Kids First 4 Ever on Substack. https://kidsfirst4ever.substack.com/
  47. Joanna, Regan J., Danielle L. Moulia, Ruth Link-Gelles, Monica Godfrey, Josephine Mak, Morgan Najdowski, et al. 2023. "Use of Updated COVID-19 Vaccines 2023–2024 Formula for Persons Aged ≥ 6 Months: Recommendations of the Advisory Committee on Immunization Practices—United States." MMWR: Recommendations and Reports 72 (42): 1140–1146. https://www.cdc.gov/mmwr/volumes/72/wr/mm7242e1.htm
  48. Shitrit, P., N. S. Zuckerman, O. Mor, B. S. Gottesman, and M. Chowers. 2021. "Nosocomial Outbreak Caused by the SARS-CoV-2 Delta Variant in a Highly Vaccinated Population, Israel, July 2021." Euro Surveillance 26 (39). https://doi.org/10.2807/1560-7917.es.2021.26.39.2100822
  49. Subramanian, S. V., and A. Kumar. 2021. "Increases in COVID-19 are Unrelated to Levels of Vaccination across 68 Countries and 2947 Counties in the United States." European Journal of Epidemiology 36: 1237–1240. https://doi.org/10.1007/s10654-021-00808-7
  50. Fraiman, J., et al. 2022. "Serious Adverse Events of Special Interest Following mRNA COVID-19 Vaccination in Randomized Trials in Adults." Vaccine (2022) 40 (40): 5798–805. https://doi.org/10.1016/j.vaccine.2022.08.036
    1. "FDA Briefing Document: EUA Amendment Request for Pfizer-BioNTech COVID-19 Vaccine for Use in Children 5 Through 11 Years of Age." fda.gov. October 26. https://www.fda.gov/media/153447/download
  52. Wallace, Megan. 2021. "ACIP COVID-19 Vaccines Work Group: Grading of Recommendations, Assessment, Development, and Evaluation (GRADE): Pfizer-BioNTech COVID-19 Vaccine." cdc.gov. May 12. https://www.cdc.gov/vaccines/acip/meetings/downloads/slides-2021-05-12/03-COVID-Wallace-508.pdf
  53. Centers for Disease Control and Prevention. U.S. Department of Health and Human Services. 2021. "Grading of Recommendations, Assessment, Development, and Evaluation (GRADE): Pfizer-BioNTech COVID-19 Vaccine for Persons Aged 12–15 Years." cdc.gov. May 14. https://www.cdc.gov/vaccines/acip/recs/grade/covid19-pfizer-biontech-vaccine-12-15-years.html#table03d
  54. Pfizer. 2022. "Fact Sheet for Healthcare Providers Administering Pfizer-BioNTech COVID-19 Vaccines (12 Years and Older): Table 11 Vaccine Efficacy—First COVID-19 Occurrence from 7 Days...Adolescents 12 Through 15 Years of Age Evaluable Efficacy (7 Days) Population." fda.gov via archive.org. January 3. https://web.archive.org/web/20220118183423/fda.gov/media/153713/download
  55. Ioannidis, John P.A. 2021. "Reconciling Estimates of Global Spread and Infection Fatality Rates of COVID-19: An Overview of Systematic Evaluations." European Journal of Clinical Investigation 51 (5). https://doi.org/10.1111/eci.13554
    1. "Physicians for Informed Consent COVID-19: Disease Information Statement (DIS)." Physicians for Informed Consent. August. https://physiciansforinformedconsent.org/wp-content/uploads/2021/08/PIC-COVID-19-Disease-Information-Statement-DIS-August-2021.pdf
  57. Ed Dowd. 2024. Cause Unknown: The Epidemic of Sudden Deaths in 2021, 2022, and 2023. Skyhorse Publishing.
  58. Lyons-Weiler, James, and Paul Thomas. 2021. "Vaccine Practice Payment Schedules Create Perverse Incentives for Unnecessary Medical Procedures—at What Cost to Patients?" International Journal of Vaccine Theory, Practice, and Research 2 (1). https://doi.org/10.56098/ijvtpr.v2i1.21
  59. Mayo Clinic. 2006. "Harnessing the Measles Virus to Attack Cancer." Science Daily, October 31. https://www.sciencedaily.com/releases/2006/10/061030143318.htm
  60. Rønne, Tove. 1985. "Measles Virus Infection without Rash in Childhood Is Related to Disease in Adult Life." The Lancet 325 (8419): 1–5. https://doi.org/10.1016/S0140-6736(85)90961-4
  61. Sasco, Annie J., and Ralph S. Paffenbarger Jr. 1985. "Measles Infection and Parkinson's Disease." American Journal of Epidemiology 122 (6): 1017–1031. https://doi.org/10.1093/oxfordjournals.aje.a114183
  62. Parodi, Stefano, et al. 2013. "Childhood Infectious Diseases and Risk of Leukaemia in an Adult Population." International Journal of Cancer 133 (8): 1892–1899. https://doi.org/10.1002/ijc.28205
  63. Shaheen, S. O., et al. 1996. "Measles and Atopy in Guinea-Bissau." The Lancet 347 (9018): 1792–1796. https://doi.org/10.1016/s0140-6736(96)91617-7
  64. Rosenlund, Helen, et al. 2009. "Allergic Disease and Atopic Sensitization in Children in Relation to Measles Vaccination and Measles Infection." Pediatrics 123 (3): 771–778. https://doi.org/10.1542/peds.2008-0013
  65. Montella, Maurizio. 2006. "Do Childhood Diseases Affect NHL and HL Risk? A Case-Control Study from Northern and Southern Italy." Leukemia Research 30 (8): 917–922. https://doi.org/10.1016/j.leukres.2005.11.020
  66. Kubota, Yasuhiko, Hiroyasu Iso, and Akiko Tamakoshi. 2015. "Association of Measles and Mumps with Cardiovascular Disease: The Japan Collaborative Cohort (JACC) Study." Atherosclerosis 241 (2): 682–686. https://doi.org/10.1016/j.atherosclerosis.2015.06.026
  67. Cramer, D. W., et al. 2010. "Mumps and Ovarian Cancer: Modern Interpretation of an Historic Association." Cancer Causes Control 21 (8): 1193–1201. https://doi.org/10.1007/s10552-010-9546-1
  68. Albonico, H. U., H. U. Braker, and J. Hüsler. 1998. "Febrile Infectious Childhood Diseases in the History of Cancer Patients and Matched Control." Medical Hypotheses 51 (4): 315–320. https://doi.org/10.1016/S0306-9877(98)90055-X
  69. Alexander, F., et al. 2000. "Risk Factors for Hodgkin's Disease by Epstein-Barr Virus (EBV) Status: Prior Infection by EBV and Other Agents." British Journal of Cancer 82 (5): 1117–1121. https://doi.org/10.1054/bjoc.1999.1049
  70. Aref, Sarah, Katharine Bailey, and Adele Fielding. 2016. "Measles to the Rescue: A Review of Oncolytic Measles Virus." Viruses 8 (10): 294. https://doi.org/10.3390/v8100294
  71. Gilham, C., et al. 2005. "Day Care in Infancy and Risk of Childhood Acute Lymphoblastic Leukaemia: Findings from UK Case-Control Study." BMJ 330: 1294. https://doi.org/10.1136/bmj.38428.521042.8F
  72. Urayama, Kevin Y., et al. 2011. "Early Life Exposure to Infections and Risk of Childhood Acute Lymphoblastic Leukemia." International Journal of Cancer 128 (7): 1632–1643. https://doi.org/10.1002/ijc.25752
  73. Silverberg, Jonathan I., et al. 2012. "Chickenpox in Childhood Is Associated with Decreased Atopic Disorders, IgE, Allergic Sensitization, and Leukocyte Subsets." Pediatric Allergy and Immunology 23 (1): 50–58. https://doi.org/10.1111/j.1399-3038.2011.01224.x
  74. Hoption Cann, Stephen A., J. P. van Netten, and C. van Netten. 2006. "Acute Infections as a Means of Cancer Prevention: Opposing Effects to Chronic Infections?" Cancer Detection and Prevention 30 (1): 83–93. https://doi.org/10.1016/j.cdp.2005.11.001
  75. Olszak, Torsten, et al. 2012. "Microbial Exposure During Early Life Has Persistent Effects on Natural Killer T Cell Function." Science 336 (6080): 489–493. https://doi.org/10.1126/science.1219328
  76. Amirian, E. Susan, et al. 2016. "History of Chickenpox in Glioma Risk: A Report from the Glioma International Case-Control Study (GICC)." Cancer Medicine 5 (6): 1352–1358. https://doi.org/10.1002/cam4.682
  77. Iheagwara, Uzoma K., et al. 2014. "Influenza Virus Infection Elicits Protective Antibodies and T Cells Specific for Host Cell Antigens Also Expressed as Tumor-Associated Antigens: A New View of Cancer Immunosurveillance." Cancer Immunology Research 2 (3): 263–273. https://doi.org/10.1158/2326-6066.CIR-13-0125
  78. Newhouse, Muriel L., et al. 1977. "A Case Control Study of Carcinoma of the Ovary." British Journal of Preventive & Social Medicine 31: 148–153. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC479015/pdf/brjprevsmed00027-0012.pdf
  79. Boraschi, Diana, Paola Italiani, Roberto Palomba, Paolo Decuzzi, Albert Duschl, Bengt Fadeel, and S. Moein Moghimi. 2017. "Nanoparticles and Innate Immunity: New Perspectives on Host Defence." Seminars in Immunology 34: 33–51. https://www.sciencedirect.com/science/article/abs/pii/S1044532317300441
  80. Shrestha, N. K., P. C. Burke, A. S. Nowacki, J. F. Simon, et al. 2023. "Effectiveness of the Coronavirus Disease 2019 Bivalent Vaccine." Open Forum Infectious Diseases 10 (6). https://doi.org/10.1093/ofid/ofad209
  81. Shrestha, N. K., P. C. Burke, A. S. Nowacki, P. Terpeluk, and S. M. Gordon. 2021. "Necessity of COVID-19 Vaccination in Previously Infected Individuals." medRxiv. https://doi.org/10.1101/2021.06.01.21258176
  82. Kojima, N., N. K. Shrestha, and J. D. Klausner. 2021. "A Systematic Review of the Protective Effect of Prior SARS-CoV-2 Infection on Repeat Infection." Evaluation & the Health Professions 44 (4): 327–332. https://doi.org/10.1177/01632787211047932
  83. Abu-Raddad, L. J., H. Chemaitelly, P. Coyle, et al. 2021. "SARS-CoV-2 Antibody-positivity Protects against Reinfection for at Least Seven Months with 95% Efficacy." EClinicalMedicine 35. https://www.sciencedirect.com/science/article/pii/S2589537021001413
  84. Harvey, R. A., J. A. Rassen, C. A. Kabelac, et al. 2021. "Association of SARS-CoV-2 Seropositive Antibody Test with Risk of Future Infection." JAMA Internal Medicine 181 (5): 672–679. https://doi.org/10.1001%2Fjamainternmed.2021.0366
  85. Jeffery-Smith, A., N. Iyanger, S. V. Williams, et al. 2021. "Antibodies to SARS-CoV-2 Protect against Re-infection during Outbreaks in Care Homes, September and October 2020." Euro Surveillance 26 (5). https://doi.org/10.2807/1560-7917.ES.2021.26.5.2100092
  86. Qureshi, A. I., W. I. Baskett, W. Huang, et al. 2022. "Reinfection with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in Patients Undergoing Serial Laboratory Testing." Clinical Infectious Diseases 74 (2): 294–300. https://doi.org/10.1093/cid/ciab345
  87. Vojdani, Aristo, Elroy Vojdani, and Datis Khar. 2020. "Reaction of Human Monoclonal Antibodies to SARS-CoV-2 Proteins with Tissue Antigens: Implications for Autoimmune Diseases." Frontiers in Immunology, Section: Autoimmune and Autoinflammatory Disorders 11. https://doi.org/10.3389/fimmu.2020.617089
  88. Moskowitz MD, Richard. 2017. Vaccines: A Reappraisal. Skyhorse Publishing.
  89. Kennedy Jr., Robert F., M. Hyman, et al. 2015. Thimerosal: Let the Science Speak: The Evidence Supporting the Immediate Removal of Mercury—a Known Neurotoxin—from Vaccines. Skyhorse Publishing.
  90. Albonico, H. U., H. U. Braker, and J. Hüsler. 1998. "Febrile Infectious Childhood Diseases in the History of Cancer Patients and Matched Control." Medical Hypotheses 51 (4): 315–320. https://doi.org/10.1016/S0306-9877(98)90055-X
  91. Blaylock, R. L. 2012. "Aluminum Induced Immunoexcitoxicity in Neurodevelopmental and Neurodegenerative Disorders." Current Inorganic Chemistry 2 (1): 46–53. https://www.eurekaselect.com/article/41192
  92. Blaylock, R. L. 2009. "A Possible Central Mechanism in Autism Spectrum Disorders, Part 2: Immunoexcitoxicity." Alternative Therapies in Health and Medicine 15 (1): 60–67. https://pubmed.ncbi.nlm.nih.gov/19161050/
  93. Blaylock, R. L., and A. Strunecka. 2009. "Immune-glutamatergic Dysfunction as a Central Mechanism of Autism Spectrum Disorders." Current Medicinal Chemistry 16 (2): 157–170. https://www.eurekaselect.com/article/13246
  94. Blaylock, R. L. 2003. "The Central Role of Excitotoxicity in Autism Spectrum Disorders." Journal of the American Nutraceutical Association 6 (1): 10–22.
  95. Blaylock, R. L. 2004. "Excitotoxicity: A Possible Central Mechanism in Fluoride Neurotoxicity." Fluoride 37 (4): 301–314. https://www.researchgate.net/publication/282499179_Excitotoxicity_A_possible_central_mechanism_in_fluoride_neurotoxicity
  96. Blaylock, R. L. 2023. "The Biochemical Basis of Neurodegenerative Disease: The Role of Immunoexcitoxicity and Possible Ways to Attenuate It." Surgical Neurology International 12 (141).
  97. Blaylock, R. L., and M. Faria. 2021. "New Concepts in the Development of Schizophrenia, Autism Spectrum Disorders, and Degenerative Brain Diseases Based on Chronic Inflammation: A Working Hypothesis from Continued Advances in Neuroscience Research." Surgical Neurology International 12 (556). https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8645502/
  98. Strunecka, A., R. L. Blaylock, M. A. Hyman, and I. Paclt. 2010. Cellular and Molecular Biology of Autism Spectrum Disorders. Edited by Anna Strunecka. Bentham Science Publishers.
  99. Strunecka, A., R. L. Blaylock, J. Patocka, and O. Strunecky. 2018. "Immunoexcitoxicity as the Central Mechanism of Etiopathology and Treatment of Autism Spectrum Disorders: A Possible Role of Fluoride and Aluminum." Surgical Neurology International 9: 74. https://surgicalneurologyint.com/surgicalint-articles/immunoexcitotoxicity-as-the-central-mechanism-of-etiopathology-and-treatment-of-autism-spectrum-disorders-a-possible-role-of-fluoride-and-aluminum/
  100. Tomljenovic, Lucija, and Christopher A. Shaw. 2011. "Aluminum Vaccine Adjuvants: Are They Safe?" Current Medicinal Chemistry 18 (17): 2630–2637. https://doi.org/10.2174/092986711795933740
  101. Exley PhD, Christopher. 2020. Imagine You Are an Aluminum Atom: Discussions with Mr. Aluminum. Skyhorse Publishing.
  102. Tian, Ayong, et al. 2015. "Vitamin D Improves Cognitive Function and Modulates Th17/Treg Cell Balance after Hepatectomy in Mice." Inflammation 38: 500–509. https://doi.org/10.1007/s10753-014-9956-4
  103. Ranganathan, P. 2009. "Genetics of Bone Loss in Rheumatoid Arthritis—Role of Vitamin D Receptor Polymorphisms." Rheumatology 48 (4): 342–346. https://doi.org/10.1093/rheumatology/ken473
  104. FLCCC Alliance. 2023. "I-RECOVER Post-Vaccine Protocol." FLCCC Alliance. July 24. https://covid19criticalcare.com/protocol/i-recover-post-vaccine-treatment/
    1. "Bruesewitz v. Wyeth LLC, 562 U.S. 223 (2011)." JUSTIA U.S. Supreme Court. February 22. https://supreme.justia.com/cases/federal/us/562/223/
  106. Olins, Jessica, ed. 2023. "Information about Vaccine Injury Payouts: The Vaccine Injury Compensation Program (NVICP)." mctlaw.com. November 3. https://www.mctlaw.com/vaccine-injury/info-about-vaccine-injury-payouts/
  107. Centers for Disease Control and Prevention. 2015. Epidemiology and Prevention of Vaccine-Preventable Diseases 13th ed. (The Pink Book). Edited by Jennifer Hamborsky, Andrew Kroger and Charles Wolfe. Washington D.C.: Public Health Foundation.
  108. Centers for Disease Control and Prevention. National Center for Health Statistics. 2015. "Vital Statistics of the United States 1937–1960." cdc.gov. November 6. https://www.cdc.gov/nchs/products/vsus.htm
    1. "Historical Statistics of the United States, Colonial Times to 1970." United States Census Bureau. September. https://www.census.gov/library/publications/1975/compendia/hist_stats_colonial-1970.html
  110. Humphries MD, Suzanne, and Roman Bystrianyk. 2013. Dissolving Illusions: Disease, Vaccines, and the Forgotten History. CreateSpace Independent Publishing Platform.
  111. Seventh Biennial Report of the Board of Health of the State of Iowa. 1893. "The Causation and Prevention of Typhoid Fever." JAMA 58.
  112. Porter, Roy. 1997. The Greatest Benefit to Mankind: A Medical History of Humanity from Antiquity to the Present. London: HarperCollins.
  113. Streiner, David L., Douglas W. MacPherson, and Brian D. Gushulak. 2010. PDQ Public Health. PMPH USA.
    1. "Scarlatina Epidemics." The British Medical Journal 2 (141): 285–286. https://www.jstor.org/stable/25200132
  115. The New York Times. 1855. "Yellow Fever—Fearful Progress of the Disease at Norfolk." September 11.
    1. "Increasing Output by Preventing Tuberculosis." The American Contractor (F.W. Dodge Corp.) 42: 366/30.
  117. Hallett, Christine. 2005. "The Attempt to Understand Puerperal Fever in the Eighteenth and the Early Nineteenth Centuries: The Influence of Inflammation Theory." Medical History 49 (1): 1–28. https://doi.org/10.1017/s0025727300000119
  118. The Gentleman's Magazine and Historical Chronical. 1764. "The Practice of Inoculation Truly Stated." 333.
  119. Fenn, Elizabeth A. 2003. "The Great Smallpox Epidemic." History Today, August. https://www.historytoday.com/archive/great-smallpox-epidemic
  120. Ratner, H., H. R. Cox, B. G. Greenberg, H. Kleinman, and P. Meier. 1960. "The Present Status of Polio Vaccines." Illinois Medical Journal, 84–93. https://ia801206.us.archive.org/17/items/illinoismedicalj1171illi/illinoismedicalj1171illi.pdf
  121. Centers for Disease Control and Prevention. 2022. "Smallpox—Vaccine Basics." cdc.gov. August 8. https://www.cdc.gov/smallpox/vaccine-basics/index.html
  122. Flexner, Abraham. 1910. Medical Education in the United States and Canada: A Report to the Carnegie Foundation for the Advancement of Teaching. Boston: D.B. Updike, The Merrymount Press. http://archive.carnegiefoundation.org/publications/pdfs/elibrary/Carnegie_Flexner_Report.pdf
  123. Gard, Sven. 1956. "Prophylactic Vaccination against Poliomyelitis." Swedish Physician's Journal. Translated for distribution by the Oak Park Health Department, Oak Park Illinois. Provided by Herbert Ratner MD.
  124. Qi, Fang, Michele Carbone, Haining Yang, and Giovanni Guadino. 2011. "Simian Virus 40 Transformation, Malignant Mesothelioma and Brain Tumors." Expert Review of Respiratory Medicine 5 (5): 683–697. https://doi.org/10.1586%2Fers.11.51
  125. Centers for Disease Control and Prevention. 2023. "2023 Recommended Immunizations for Children from Birth Through 6 Years Old." https://www.cdc.gov/vaccines/parents/downloads/parent-ver-sch-0-6yrs.pdf
  126. Anonymous. 2022. Turtles All the Way Down: Vaccine Science and Myth. Edited by Zoey O'Toole and Mary Holland. ISBN: 978-965-598-104-9. The Turtles Team.
  127. Anonymous. 2022. Turtles All the Way Down—References. Edited by Zoey O'Toole and Mary Holland. https://drive.google.com/file/d/16qHPe0odDOweuCDlwIEjarF4Aiu7oyM9/view
  128. Sanofi Pasteur. "Package Insert: DAPTACEL (Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine Adsorbed)." fda.gov. https://www.fda.gov/media/74035/download
  129. GlaxoSmithKline (GSK). 1997. "Package Insert: INFANRIX (Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine Adsorbed) Suspension for Intramuscular Injection." fda.gov. https://www.fda.gov/media/75157/download
  130. Siri & Glimstad LLP. 2021. "January 28, 2021 Letter to Special Rapporteur on Extreme Poverty and Human Rights, Re: Death of Infants in Certain Developing Countries by Systematic Use of a Biologic." Informed Consent Action Network. January 28. https://icandecide.org/wp-content/uploads/2021/06/2021.01.28-Letter-to-Special-Rapporteur-on-Poverty.pdf
    1. "The Swedish Trial: Clinical Review of Biological License Application DAPTACEL (CPDT)." April 9. https://drive.google.com/file/d/1CFrePXwN-q5ywCnuflnwLjUwScsLPvBU/view
  132. Sanofi Pasteur. 2022. "Package Insert: ActHIB [Haemophilus b Conjugate Vaccine (Tetanus Toxoid Conjugate)] Solution for Intramuscular Injection." fda.gov. March. https://www.fda.gov/media/74395/download
  133. GlaxoSmithKline (GSK). 2009. "Package Insert: HIBERIX [Haemophilus b Conjugate Vaccine (Tetanus Toxoid Conjugate)] for injection, for intramuscular use." fda.gov. https://www.fda.gov/media/77017/download
  134. FDA, Division of Vaccines and Related Products Applications. 2009. "Hiberix BLA Clinical Review." fda.gov via archive-it.org. July 8. https://wayback.archive-it.org/7993/20190930090059/https://www.fda.gov/files/vaccines,%20blood%20&%20biologics/published/Clinical-Review---July-8--2009---Hiberix.pdf
  135. Merck & Co., Inc. 1998. "Package Insert: Liquid PedvaxHIB®." fda.gov. https://www.fda.gov/media/80438/download
  136. Sanofi Pasteur. 2022. "Package Insert: IPOL®, Poliovirus Vaccine Inactivated." fda.gov. May. https://www.fda.gov/media/75695/download
  137. Black, S., H. Shinefield, B. Fireman, E. Lewis, P. Ray, J. R. Hansen, L. Elvin, K. M. Ensor, J. Hackell, et al. 2000. "Efficacy, Safety and Immunogenicity of Heptavalent Pneumococcal Conjugate Vaccine in Children." The Pediatric Infectious Disease Journal 19 (3): 187–195. https://journals.lww.com/pidj/abstract/2000/03000/efficacy,_safety_and_immunogenicity_of_heptavalent.3.aspx
  138. Pfizer. 2010. "Package Insert: PREVNAR 13 (Pneumococcal 13-valent Conjugate Vaccine [Diphtheria CRM197 Protein])." fda.gov. https://www.fda.gov/media/107657/download
  139. Merck & Co., Inc. 2021. "Package Insert: VAXNEUVANCE™ (Pneumococcal 15-valent Conjugate Vaccine)." fda.gov. https://www.fda.gov/media/150819/download
  140. Pfizer. 2021. "Package Insert: PREVNAR 20® (Pneumococcal 20-valent Conjugate Vaccine)." fda.gov. https://www.fda.gov/media/149987/download
  141. Mongeau, Tina Khoie. 2021. "BLA Clinical Review Memorandum: PREVNAR 20." fda.gov. June 8. https://www.fda.gov/media/150459/download
  142. GlaxoSmithKline (GSK). 2023. "Package Insert: ENGERIX-B [Hepatitis B Vaccine (Recombinant)] injectable suspension, for intramuscular use." gskpro.com. October. https://gskpro.com/content/dam/global/hcpportal/en_US/Prescribing_Information/Engerix-B/pdf/ENGERIX-B.PDF
    1. "FDA August 20, 2018 MMRII FOIA Response, re: file 2018-6847 (see clinical reports)." Siri & Glimstad LLC. March 27. https://www.sirillp.com/wp-content/uploads/2023/07/MMRII-FOIA.pdf
  144. GlaxoSmithKline (GSK). 2022. "Package Insert: PRIORIX (Measles, Mumps, and Rubella Vaccine, Live)." fda.gov. https://www.fda.gov/media/158941/download
  145. Klein, Nicola P., et al. 2019. "Supplementary Materials: Immunogenicity and Safety of MMR Vaccine." ncbi.nlm.nih.gov. November 14. https://link.sbstck.com/redirect/874a1ea9-b86c-45ad-a49e-6978a20d9e8a?j=eyJ1IjoicmtsMjUifQ.8Q4vB5un1FDjnC-Y46_-FvMQmk6OF4UZj6X51K1H1TA
  146. Ruiz-Palacios, Guillermo M., I. Pérez-Schael, F. Velázquez, H. Abate, Human Rotavirus Vaccine Study Group, et al. 2006. "Safety and Efficacy of an Attenuated Vaccine against Severe Rotavirus Gastroenteritis." The New England Journal of Medicine 354 (1): 11–22. https://doi.org/10.1056/nejmoa052434
  147. GlaxoSmithKline (GSK). 2008. "Package Insert: ROTARIX (Rotavirus Vaccine, Live, Oral)." fda.gov. https://www.fda.gov/media/163009/download
  148. FDA, Division of Vaccines and Related Products Applications. 2008. "Clinical Review for STN 125265/0 Rotarix: Rotavirus Vaccine, Live, Oral." fda.gov via archive-it.org. March 10. https://wayback.archive-it.org/7993/20170722073219/https://www.fda.gov/downloads/BiologicsBloodVaccines/Vaccines/ApprovedProducts/UCM133580.pdf
  149. Merck & Co., Inc. 2006. "Package Insert: RotaTeq (Rotavirus Vaccine, Live, Oral, Pentavalent)." fda.gov. https://www.fda.gov/media/75718/download
    1. "FDA May 8, 2018 RotaTeq placebo FOIA Response, re: file 2018-3994 (see clinical reports)." Informed Consent Action Network. June 14. https://icandecide.org/wp-content/uploads/2023/06/rotateq_placebo.pdf
  151. Pfizer. 2023. "Package Insert: COMIRNATY® (COVID-19 Vaccine, mRNA) suspension for injection, for intramuscular use 2023-2024 Formula." fda.gov. October. https://www.fda.gov/media/151707/download
  152. Lyons-Weiler, James, and Paul Thomas. 2020. "Relative Incidence of Office Visits and Cumulative Rates of Billed Diagnoses along the Axis of Vaccination." International Journal of Environmental Research and Public Health 17 (22): 8674. https://doi.org/10.3390/ijerph17228674
  153. Lazarus, Ross. 2010. Electronic Support for Public Health—Vaccine Adverse Event Reporting System (ESP:VAERS). Grant Final Report, The Agency for Healthcare Research and Quality (AHRQ) U.S. Department of Health and Human Services, Boston: Harvard Pilgrim Health Care, Inc. https://digital.ahrq.gov/ahrq-funded-projects/electronic-support-public-health-vaccine-adverse-event-reporting-system
  154. Shoenfeld, Yehuda, Nancy Agmon-Levin, and Lucija Tomljenovic. 2015. Vaccines and Autoimmunity. Wiley-Blackwell.
  155. Exley PhD, Christopher. 2020. Imagine You Are an Aluminum Atom: Discussions with Mr. Aluminum. Skyhorse Publishing.
  156. Zatta, P. F., and A. C. Alfrey. 1997. Aluminium Toxicity in Infants' Health and Disease. World Scientific Pub Co Inc.
  157. Yokel, Robert, and Mari Golub. 1996. Research Issues in Aluminium Toxicity. Washington, D.C.: Taylor & Francis.
  158. Agency for Toxic Substances and Disease Registry (ATSDR). 2008. "Toxicological Profile for Aluminum." September. https://www.atsdr.cdc.gov/ToxProfiles/tp22.pdf
  159. Bishop, Nicholas J., Ruth Morley, J. Philip Day, and Alan Lucas. 1997. "Aluminum Neurotoxicity in Preterm Infants Receiving Intravenous-Feeding Solutions." New England Journal of Medicine 336: 1557–1562. https://www.nejm.org/doi/full/10.1056/NEJM199705293362203
  160. Poole, Robert L., Kevin P. Pieroni, Shabnam Gaskari, Tessa K. Dixon, K. T. Park, and John A. Kerner Jr. 2011. "Aluminum in Pediatric Parenteral Nutrition Products: Measured Versus Labeled Content." The Journal of Pediatric Pharmacology and Therapeutics 16 (2): 92–97. https://doi.org/10.5863%2F1551-6776-16.2.92
  161. McFarland, Grant, Elaine La Joie, Paul Thomas, and James Lyons-Weiler. 2020. "Acute Exposure and Chronic Retention of Aluminum in Three Vaccine Schedules and Effects of Genetic and Environmental Variation." Journal of Trace Elements in Medicine and Biology 58. https://doi.org/10.1016/j.jtemb.2019.126444
  162. McFarland, Grant, Elaine La Joie, Paul Thomas, and James Lyons-Weiler. 2020. "Acute Exposure and Chronic Retention of Aluminum in Three Vaccine Schedules and Effects of Genetic and Environmental Variation." Journal of Trace Elements in Medicine and Biology 58. https://doi.org/10.1016/j.jtemb.2019.126444
  163. Lyons-Weiler, James, and Robert Ricketson. 2018. "Reconsideration of the Immunotherapeutic Pediatric Safe Dose Levels of Aluminum." Journal of Trace Elements in Medicine and Biology 48: 67–73. https://doi.org/10.1016/j.jtemb.2018.02.025
  164. Andress, Dennis L., Jeffrey B. Kopp, Norma A. Maloney, Jack W. Coburn, and Donald J. Sherrard. 1987. "Early Deposition of Aluminum in Bone in Diabetic Patients on Hemodialysis." The New England Journal of Medicine 316: 292–296. https://www.nejm.org/doi/full/10.1056/NEJM198702053160602
  165. Priest, N. D., D. Newton, J. P. Day, R. J. Talbot, and A. J. Warner. 1995. "Human Metabolism of Aluminium-26 and Gallium-67 Injected as Citrates." Human & Experimental Toxicology 14 (3): 287–293. https://doi.org/10.1177/096032719501400309
  166. American Academy of Pediatrics, Committee on Nutrition. 1996. "Aluminum Toxicity in Infants and Children." Pediatrics 97 (3): 413–416. https://pubmed.ncbi.nlm.nih.gov/8604282/
  167. Priest, N. D. 2004. "The Biological Behaviour and Bioavailability of Aluminium in Man, with Special Reference to Studies Employing Aluminium-26 as a Tracer: Review and Study Update." Journal of Environmental Monitoring 6 (5): 376, 392. https://doi.org/10.1039/b314329p
  168. Poole, Robert L., Kevin P. Pieroni, Shabnam Gaskari, Tessa K. Dixon, K. T. Park, and John A. Kerner Jr. 2011. "Aluminum in Pediatric Parenteral Nutrition Products: Measured Versus Labeled Content." The Journal of Pediatric Pharmacology and Therapeutics 16 (2): 92–97. https://doi.org/10.5863%2F1551-6776-16.2.92
  169. Masson, Jean-Daniel, Guillemette Crépeaux, et al. 2018. "Critical Analysis of Reference Studies on the Toxicokinetics of Aluminum-based Adjuvants." Journal of Inorganic Biochemistry 181: 87–95. https://doi.org/10.1016/j.jinorgbio.2017.12.015
    1. "FDA Drug Safety and Availability: Infants at Risk for Aluminum Toxicity with Unapproved Potassium Phosphates Drug Product." fda.gov on Pagefreezer Website archive. February 9. https://public4.pagefreezer.com/browse/FDA/16-12-2023T13:09/https:/www.fda.gov/drugs/drug-safety-and-availability/infants-risk-aluminum-toxicity-unapproved-potassium-phosphates-drug-product
    1. "Physicians for Informed Consent Aluminum: Vaccine Risk Statement (VRS)." Physicians for Informed Consent. https://physiciansforinformedconsent.org/PIC-Aluminum-VRS.pdf
  172. Exley, Christopher. 2004. "The Pro-oxidant Activity of Aluminum." Free Radical Biology and Medicine 36 (3): 380–387. https://doi.org/10.1016/j.freeradbiomed.2003.11.017
  173. Cao, Zheng, Xu Yang, Haiyang Zhang, Haoran Wang, Wanyue Huang, Feibo Xu, Cuicui Zhuang, Xiaoguang Wang, and Yanfei Li. 2016. "Aluminum Chloride Induces Neuroinflammation, Loss of Neuronal Dendritic Spine and Cognition Impairment in Developing Rat." Chemosphere 151: 289–295. https://www.sciencedirect.com/science/article/abs/pii/S0045653516302533
  174. Khafaga, Asmaa Fahmy. 2017. "Exogenous Phosphatidylcholine Supplementation Retrieve Aluminum-induced Toxicity in Male Albino Rats." Environmental Science and Pollution Research 24 (18): 15589–15598. https://doi.org/10.1007/s11356-017-9151-x
  175. Kool, Mirjam, Virginie Pétrilli, Thibaut De Smedt, Aline Rolaz, Hamida Hammad, Menno van Nimwegen, Ingrid M. Bergen, Rosa Castillo, Bart N. Lambrecht, and Jürg Tschopp. 2008. "Cutting Edge: Alum Adjuvant Stimulates Inflammatory Dendritic Cells through Activation of the NALP3 Inflammasome." Journal of Immunology 181 (6): 3755–3759. https://doi.org/10.4049/jimmunol.181.6.3755
  176. Shaw, Christopher A., and Michael S. Petrik. 2009. "Aluminum Hydroxide Injections Lead to Motor Deficits and Motor Neuron Degeneration." Journal of Inorganic Biochemistry 103 (11): 1555–1562. https://doi.org/10.1016/j.jinorgbio.2009.05.019
  177. Takano, Tomoyuki. 2015. "Role of Microglia in Autism: Recent Advances." Developmental Neuroscience 37 (3): 195–202. https://doi.org/10.1159/000398791
  178. Viezeliene, Dale, et al. 2013. "Selective Induction of IL-6 by Aluminum-induced Oxidative Stress Can Be Prevented by Selenium." Journal of Trace Elements in Medicine and Biology 27 (3): 226–229. https://doi.org/10.1016/j.jtemb.2012.11.001
  179. Alawdi, Shawqi H., et al. 2017. "Neuroprotective Effect of Nanodiamond in Alzheimer's Disease Rat Model: A Pivotal Role for Modulating NF-κB and STAT3 Signaling." Molecular Neurobiology 54: 1906–1918. https://doi.org/10.1007/s12035-016-9762-0
  180. Eikelenboom, Piet, Erik van Exel, Jeroen J. M. Hoozemans, et al. 2010. "Neuroinflammation—An Early Event in Both the History and Pathogenesis of Alzheimer's Disease." Neurodegenerative Diseases 7 (1-3): 38–41. https://doi.org/10.1159/000283480
  181. Lahiri, Debomoy K., Nasser H. Zawia, Nigel H. Greig, et al. 2008. "Early-Life Events May Trigger Biochemical Pathways for Alzheimer's Disease: The 'LEARn' Model." Biogerontology 9 (6): 375–379. https://doi.org/10.1007/s10522-008-9162-6
  182. Bilbo, Staci D., Carina L. Block, Jessica L. Bolton, et al. 2018. "Beyond Infection—Maternal Immune Activation by Environmental Factors, Microglial Development, and Relevance for Autism Spectrum Disorders." Experimental Neurology 299 (Part A): 241–251. https://doi.org/10.1016/j.expneurol.2017.07.002
  183. Parker-Athill, E. Carla, and Jun Tan. 2011. "Maternal Immune Activation and Autism Spectrum Disorder: Interleukin-6 Signaling as a Key Mechanistic Pathway." Neurosignals 18 (2): 113–128. https://doi.org/10.1159/000319828
  184. Butle, S. R., S. P. Gajare, A. P. Deshpande, et al. 2012. "Recent Advances in the Management of Autism: A Review." Inventi Rapid: Ethnopharmacology 2012 (4). https://www.researchgate.net/publication/293827739_Recent_Advances_in_the_Management_of_Autism_A_Review
  185. Careaga, Milo, Takeshi Murai, and Melissa D. Bauman. 2017. "Maternal Immune Activation and Autism Spectrum Disorder: From Rodents to Nonhuman and Human Primates." Biological Psychiatry 81 (5): 391–401. https://doi.org/10.1016/j.biopsych.2016.10.020
  186. Bilbo, Staci D., and Jaclyn M. Schwarz. 2009. "Early-Life Programming of Later-Life Brain and Behavior: A Critical Role for the Immune System." Frontiers in Behavioral Neuroscience 3, Article 14: 1–14. https://doi.org/10.3389/neuro.08.014.2009
  187. Giannotta, G., and N. Giannotta. 2018. "Vaccines and Neuroinflammation." International Journal of Public Health & Safety 3 (3): 163. https://childrenshealthdefense.org/wp-content/uploads/Giannotta-2018-Vaccines-and-neuroinflammation-.pdf
  188. Vargas, Diana L, Caterina Nascimbene, Chitra Krishnan, Andrew W. Zimmerman, and Carlos A. Pardo. 2005. "Neuroglial Activation and Neuroinflammation in the Brain of Patients with Autism." Annals of Neurology 57 (1): 67–81. https://doi.org/10.1002/ana.20315
  189. GlaxoSmithKline (GSK). 2023. "Package Insert: BOOSTRIX (Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine, Adsorbed)." gskpro.com. October. https://gskpro.com/content/dam/global/hcpportal/en_US/Prescribing_Information/Boostrix/pdf/BOOSTRIX.PDF
  190. Warfel, Jason M., Lindsey I. Zimmerman, and Tod J. Merkel. 2013. "Acellular Pertussis Vaccines Protect against Disease but Fail to Prevent Infection and Transmission in a Nonhuman Primate Model." Proceedings of the National Academy of Sciences of the United States of America 111 (2): 787–792. https://doi.org/10.1073/pnas.1314688110
  191. Barkoff, Alex-Mikael, Jussi Mertsola, Sophie Guillot, Nicole Guiso, Guy Berbers, and Qiushui He. 2012. "Appearance of Bordetella Pertussis Strains Not Expressing the Vaccine Antigen Pertactin in Finland." Clinical and Vaccine Immunology 19 (10): 1703–1704. https://journals.asm.org/doi/10.1128/cvi.00367-12
  192. Queenan, Anne Marie, Pamela K. Cassiday, and Alan Evangelista. February. "Pertactin-negative Variants of Bordetella Pertussis in the United States." The New England Journal of Medicine 368 (6): 583–584. https://doi.org/10.1056/nejmc1209369
  193. Otsuka, Nao, Hyun-Ja Han, Hiromi Toyoizumi-Ajisaka, Yukitsugu Nakamura, Yoshichika Arakawa, Keigo Shibayama, and Kazunari Kamachi. 2012. "Prevalence and Genetic Characterization of Pertactin-Deficient Bordetella Pertussis in Japan." PLoS One 7 (2). https://doi.org/10.1371/journal.pone.0031985
  194. Stefanelli, Paola, Cecilia Fazio, Giorgio Fedele, Fabiana Spensieri, Clara Maria Ausiello, and Paola Mastrantonio. 2009. "A Natural Pertactin Deficient Strain of Bordetella Pertussis Shows Improved Entry in Human Monocyte-derived Dendritic Cells." The New Microbiologica 32 (2): 159–166. https://pubmed.ncbi.nlm.nih.gov/19579693/
  195. Zheteyeva, Yenlik A., Pedro L. Moro, Naomi K. Tepper, Sonja A. Rasmussen, Faith E. Barash, Natalia V. Revzina, Dmitry Kissin, et al. 2012. "Adverse Event Reports after Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccines in Pregnant Women." American Journal of Obstetrics & Gynecology 207 (1). https://doi.org/10.1016/j.ajog.2012.05.006
  196. Kharbanda, Elyse O., et al. 2014. "Evaluation of the Association of Maternal Pertussis Vaccination with Obstetric Events and Birth Outcomes." JAMA 312 (18): 1897–1904. https://doi.org/10.1001/jama.2014.14825
  197. Layton, Bradley J., et al. 2017. "Prenatal Tdap Immunization and Risk of Maternal and Newborn Adverse Events." Vaccine 35 (33): 4072–4078. https://doi.org/10.1016/j.vaccine.2017.06.071
  198. DeSilva, Malini, et al. 2017. "Maternal Tdap Vaccination and Risk of Infant Morbidity." Vaccine 35 (29): 3655–3660. https://doi.org/10.1016/j.vaccine.2017.05.041
  199. Baxter, Roger, Joan Bartlett, Ali Rowhani-Rahbar, Bruce Fireman, and Nicola P. Klein. 2013. "Effectiveness of Pertussis Vaccines for Adolescents and Adults: Case-Control Study." BMJ 347. https://www.bmj.com/content/347/bmj.f4249
  200. Koepke, Ruth, Jens C. Eickhoff, Roman A. Ayele, et al. 2014. "Estimating the Effectiveness of Tetanus-Diphtheria-Acellular Pertussis Vaccine (Tdap) for Preventing Pertussis: Evidence of Rapidly Waning Immunity and Difference in Effectiveness by Tdap Brand." The Journal of Infectious Diseases 210 (6): 942–953. https://doi.org/10.1093/infdis/jiu322
  201. Witt, Maxwell A., Paul H. Katz, and David J. Witt. 2012. "Unexpectedly Limited Durability of Immunity Following Acellular Pertussis Vaccination in Preadolescents in a North American Outbreak." Clinical Infectious Diseases 54 (12): 1730–1735. https://doi.org/10.1093/cid/cis287
  202. Griffin, R. Morgan. 2022. "What Are Your Odds of Getting the Flu?" WebMD.com, November 19. https://www.webmd.com/cold-and-flu/flu-statistics
  203. Centers for Disease Control and Prevention. 2023. "Influenza (Flu) Past Seasons' Vaccine Effectiveness Estimates." cdc.gov. June 2. https://www.cdc.gov/flu/vaccineswork/past-seasons-estimates.html
  204. Rikin, S., H. Jia, C.Y. Vargas, Y. Castellanos de Belliard, C. Reed, P. LaRussa, E. L. Larson, L. Saiman, and M. S. Stockwell. 2018. "Assessment of Temporally-related Acute Respiratory Illness following Influenza Vaccination." Vaccine 36 (15): 1958–1964. https://doi.org/10.1016%2Fj.vaccine.2018.02.105
  205. Dierig, A., L. G. Heron, S. B. Lambert, J. K. Yin, J. Leask, M. Y. Chow, T. P. Sloots, M. D. Nissen, I. Ridda, and R. Booy. 2014. "Epidemiology of Respiratory Viral Infections in Children Enrolled in a Study of Influenza Vaccine Effectiveness." Influenza and Other Respiratory Viruses 8 (3): 293–301. https://doi.org/10.1111/irv.12229
  206. Rikin, S., H. Jia, C.Y. Vargas, Y. Castellanos de Belliard, C. Reed, P. LaRussa, E. L. Larson, L. Saiman, and M. S. Stockwell. 2018. "Assessment of Temporally-related Acute Respiratory Illness Following Influenza Vaccination." Vaccine 36 (15): 1958–1964. https://doi.org/10.1016%2Fj.vaccine.2018.02.105
  207. Centers for Disease Control and Prevention. 2022. "Selecting Viruses for the Seasonal Influenza Vaccine." cdc.gov. November. https://www.cdc.gov/flu/prevent/vaccine-selection.htm
  208. Demicheli, V., T. Jefferson, E. Ferroni, A Rivetti, and C. Di Pietrantonj. 2018. "Vaccines for Preventing Influenza in Healthy Adults." Cochrane Database of Systematic Reviews 2 (2). https://doi.org/10.1002/14651858.cd001269.pub6
  209. Jefferson, T., C. Di Pietrantonj, A. Rivetti, G. A. Bawazeer, L. A. Al‐Ansary, and E. Ferroni. 2010. "Vaccines for Preventing Influenza in Healthy Adults." Cochrane Database of Systematic Reviews (7). https://doi.org/10.1002/14651858.CD001269.pub4
  210. Ohmit, S. E., J. G. Petrie, R. E. Malosh, B. J. Cowling, M. G. Thompson, D. K. Shay, and A. S. Monto. 2013. "Influenza Vaccine Effectiveness in the Community and the Household." Clinical Infectious Diseases 56 (10): 1363–1369. https://doi.org/10.1093%2Fcid%2Fcit060
    1. "Physicians for Informed Consent Vaccines and Immunocompromised Schoolchildren: Risk Group Information Statement (RGIS)." Physicians for Informed Consent. July. https://physiciansforinformedconsent.org/immunocompromised-schoolchildren/rgis/
  212. Goldman, G. S. 2013. "Comparison of VAERS Fetal-loss Reports During Three Consecutive Influenza Seasons: Was There a Synergistic Fetal Toxicity Associated with the Two-vaccine 2009/2010 Season?" Human & Experimental Toxicology 32 (5): 464–475. https://doi.org/10.1177/0960327112455067
  213. Donahue, James G., Burney A. Kieke, Jennifer P. King, Frank DeStefano, Maria A. Mascola, et al. 2017. "Association of Spontaneous Abortion with Receipt of Inactivated Influenza Vaccine Containing H1N1pdm09 in 2010-11 and 2011-12." Vaccine 35 (40): 5314–5322. https://doi.org/10.1016/j.vaccine.2017.06.069
  214. Zerbo, Ousseny, Yinge Qian, Cathleen Yoshida, Bruce Fireman, Nicola P. Klein, and Lisa A. Croen. 2017. "Association Between Influenza Infection and Vaccination During Pregnancy and Risk of Autism Spectrum Disorder." JAMA Pediatrics 171 (1). https://doi.org/10.1001/jamapediatrics.2016.3609
  215. Christian, Lisa M., et al. 2011. "Inflammatory Responses to Trivalent Influenza Virus Vaccine among Pregnant Women." Vaccine 29 (48): 8982–8987. https://doi.org/10.1016/j.vaccine.2011.09.039
  216. Blaylock, R. L. Summer 2004. "Chronic Microglial Activation and Excitotoxicity Secondary to Excessive Immune Stimulation: Possible Factors in Gulf War Syndrome and Autism." Journal of American Physicians and Surgeons 9 (2): 46–51. https://www.jpands.org/vol9no2/blaylock.pdf
  217. Centers for Disease Control and Prevention. n.d. "CDC Wonder: About Underlying Cause of Death, 1999–2020." cdc.gov. https://web.archive.org/web/20240223043502/https://wonder.cdc.gov/ucd-icd10.html
  218. Harper, S. A., K. Fukuda, T. M. Uyeki, N. J. Cox, C. B. Bridges, and Centers for Disease Control and Prevention (CDC) A. 2004. "Prevention and Control of Influenza: Recommendations of the Advisory Committee on Immunization Practices (ACIP)." MMWR: Recommendations and Reports 53 (RR-6): 1–40. https://pubmed.ncbi.nlm.nih.gov/15163927/
  219. Joshi, A. Y., V. N. Iyer, et al. 2012. "Effectiveness of Trivalent Inactivated Influenza Vaccine in Influenza-related Hospitalization in Children: A Case-Control Study." Allergy and Asthma Proceedings 33 (2). https://doi.org/10.2500/aap.2012.33.3513
  220. Jain, Samhita, Rebecca J. Baer, Charles E. McCulloch, et al. 2021. "Association of Maternal Immune Activation during Pregnancy and Neurologic Outcomes in Offspring." The Journal of Pediatrics 238: 87–93. https://doi.org/10.1016/j.jpeds.2021.04.069
  221. Cowling, Benjamin J., Vicky J. Fang, Hiroshi Nishiura, et al. 2012. "Increased Risk of Noninfluenza Respiratory Virus Infections Associated with Receipt of Inactivated Influenza Vaccine." Clinical Infectious Diseases 54 (12): 1778–1783. https://doi.org/10.1093/cid/cis307
  222. Centers for Disease Control and Prevention. 2022. "Symptoms of COVID-19." cdc.gov. October 26. https://www.cdc.gov/coronavirus/2019-ncov/symptoms-testing/symptoms.html
  223. Perez, Jean Claude, Claire Moret-Chalmin, and Luc Montagnier. 2022. "Towards the Emergence of a New Form of the Neurodegenerative Creutzfeldt-Jakob Disease: Twenty-Six Cases of CJD Declared a Few Days after a COVID-19 'Vaccine' Jab (Version V4)." Zenodo. https://doi.org/10.5281/zenodo.6641998
  224. DeSilva, Malini, et al. 2022. "Evaluation of Acute Adverse Events after Covid-19 Vaccination during Pregnancy." The New England Journal of Medicine 387 (2): 187–189. https://doi.org/10.1056/NEJMc2205276
  225. Dick, Aharon, et al. 2022. "Safety of SARS-CoV-2 Vaccination during Pregnancy—Obstetric Outcomes from a Large Cohort Study." BMC Pregnancy Childbirth 22 (166). https://doi.org/10.1186/s12884-022-04505-5
  226. Kennedy Jr., Robert F., and Brian Hooker. 2023. Vax-Unvax: Let the Science Speak. Skyhorse Publishing.
  227. Montano, Diego. 2022. "Frequency and Associations of Adverse Reactions of COVID-19 Vaccines Reported to Pharmacovigilance Systems in the European Union and the United States." Frontiers in Public Health, Section: Infectious Diseases—Surveillance, Prevention and Treatment 9. https://doi.org/10.3389/fpubh.2021.756633
  228. Aaby, Peter, Christine S. Benn, Katie L. Flanagan, Sabra L. Klein, Tobias R. Kollmann, David J. Lynn, and Frank Shann. 2020. "The Non-specific and Sex-differential Effects of Vaccines." Nature Reviews Immunology 20: 464–470. https://www.nature.com/articles/s41577-020-0338-x
  229. Leeyaphan, Charussri, et al. 2023. "Herpes Zoster after COVID-19 Infection or Vaccination: A Prospective Cohort Study in a Tertiary Dermatology Clinic." Dermatology Research and Practice 2023: 8 pages. https://doi.org/10.1155/2023/2206498
  230. Berild, Jacob D., Vilde B. Larsen, Emilia M. Thiesson, et al. 2022. "Analysis of Thromboembolic and Thrombocytopenic Events after the AZD1222, BNT162b2, and MRNA-1273 COVID-19 Vaccines in 3 Nordic Countries." JAMA Network Open 5 (6). https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2793348
  231. Mevorach, Dror, et al. 2021. "Myocarditis after BNT162b2 mRNA Vaccine against Covid-19 in Israel." The New England Journal of Medicine 385: 2140–2149. https://doi.org/10.1056/NEJMoa2109730
  232. Massari, Marco, et al. 2022. "Postmarketing Active Surveillance of Myocarditis and Pericarditis following Vaccination with COVID-19 mRNA Vaccines in Persons Aged 12 to 39 Years in Italy: A Multi-database, Self-controlled Case Series Study." PLoS Medicine 19 (7). https://doi.org/10.1371/journal.pmed.1004056
  233. Simone, Anthony, et al. 2022. "Acute Myocarditis following a Third Dose of COVID-19 mRNA Vaccination in Adults." International Journal of Cardiology 65: 41–43. https://doi.org/10.1016/j.ijcard.2022.07.031
  234. Patone, Martina, et al. 2022. "Risk of Myocarditis after Sequential Doses of COVID-19 Vaccine and SARS-CoV-2 Infection by Age and Sex." Circulation 146 (10). https://doi.org/10.1161/CIRCULATIONAHA.122.059970
  235. Karlstad, Øystein, et al. 2022. "SARS-CoV-2 Vaccination and Myocarditis in a Nordic Cohort Study of 23 Million Residents." JAMA Cardiology 7 (6): 600–612. https://doi.org/10.1001/jamacardio.2022.0583
  236. Lai, Daoyuan, et al. 2022. "Risk of Myocarditis after Two Doses of COVID-19 mRNA Vaccines in the US, 2020–2022: A Self-controlled Case Series Study [PREPRINT (Version 1)]." Research Square. https://doi.org/10.21203/rs.3.rs-1741089/v1
  237. Hulscher, Nicholas, Michael Cook, Raphael Stricker, and Peter A. McCullough. 2024. "Excess Cardiopulmonary Arrest and Mortality after COVID-19 Vaccination in King County, Washington." Preprints, 2024051665. https://doi.org/10.20944/preprints202405.1665.v1
  238. Centers for Disease Control and Prevention. 2021. "Vaccines and Immunizations: Definition of Terms." cdc.gov. September 1. https://www.cdc.gov/vaccines/vac-gen/imz-basics.htm
  239. Centers for Disease Control and Prevention. 2021. "Chapter 10: Hepatitis B." In Epidemiology and Prevention of Vaccine-Preventable Diseases 14th ed. (The Pink Book), edited by Penina Haber and Sarah Schillie. Washington, D.C.: Public Health Foundation. https://www.cdc.gov/vaccines/pubs/pinkbook/downloads/hepb.pdf
  240. Magno, Hector, and Beatrice Golomb. 2020. "Measuring the Benefits of Mass Vaccination Programs in the United States." Vaccines 8 (4): 561. https://doi.org/10.3390%2Fvaccines8040561
  241. Roberts, Henry, Deanna Kruszon-Moran, Kathleen N. Ly, Elizabeth Hughes, Kashif Iqbal, Ruth B. Jiles, and Scott D. Holmberg. 2016. "Prevalence of Chronic Hepatitis B Virus (HBV) Infection in U.S. Households: National Health and Nutrition Examination Survey (NHANES), 1988–2012." Hepatology 63 (2): 388–397. https://doi.org/10.1002/hep.28109
  242. Gallagher, Carolyn M., and Melody S. Goodman. 2010. "Hepatitis B Vaccination of Male Neonates and Autism Diagnosis, NHIS 1997–2002." Journal of Toxicology and Environmental Health, Part A 73 (24): 1665–1677. https://doi.org/10.1080/15287394.2010.519317
  243. Fisher, Monica A., and Stephen A. Eklund. 1999. "Hepatitis B Vaccine and Liver Problems in U.S. Children Less Than 6 Years Old, 1993 and 1994." Epidemiology 10 (3): 337–339. https://pubmed.ncbi.nlm.nih.gov/10230847/
  244. Hernán, Miguel A., Susan S. Jick, Michael J. Olek, and Hershel Jick. 2004. "Recombinant Hepatitis B Vaccine and the Risk of Multiple Sclerosis." Neurology 63 (5): 838–842. https://doi.org/10.1212/01.WNL.0000138433.61870.82
  245. Classen, David C., and John B. Classen. 1997. "Hypothesis: The Timing of Pediatric Immunization and the Risk of Insulin-Dependent Diabetes Mellitus." Infectious Diseases in Clinical Practice 6 (7): 449–454. https://journals.lww.com/infectdis/citation/1997/06070/the_timing_of_pediatric_immunization_and_the_risk.7.aspx
  246. Yon, Dong Keong, et al. 2018. "Hepatitis B Immunogenicity after a Primary Vaccination Course Associated with Childhood Asthma, Allergic Rhinitis, and Allergen Sensitization." Pediatric Allergy and Immunology (PAI) 29 (2): 221–224. https://doi.org/10.1111/pai.12850
  247. Puliyel, J, P. Naik, A. Puliyel, K. Agarwal, V. Lal, N. Kansal, D. Nandan, et al. 2018. "Evaluation of the Protection Provided by Hepatitis B Vaccination in India." Indian Journal of Pediatrics 85 (7): 510–516. https://doi.org/10.1007/s12098-017-2601-0
  248. Cornelissen, M., R. von Kries, P. Loughnan, and G. Schubiger. 1997. "Prevention of Vitamin K Deficiency Bleeding: Efficacy of Different Multiple Oral Dose Schedules of Vitamin K." European Journal of Pediatrics 156 (2): 126–130. https://doi.org/10.1007/s004310050570
  249. Links to results of three clinical trials on ClinicalTrials.gov: NCT03979313 | NCT02878330 | NCT03959488
  250. AstraZeneca. 2023. "Package Insert: BEYFORTUS (nirsevimab-alip) injection, for intramuscular use Initial U.S. Approval: 2023." fda.gov. July. https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/761328s000lbl.pdf
  251. Prill, Mila M., Gayle E. Langley, Amber Winn, and Susan I. Gerber. 2021. "Respiratory Syncytial Virus‐associated Deaths in the United States according to Death Certificate, 2005 to 2016." Health Science Reports 4 (4). https://doi.org/10.1002%2Fhsr2.428
  252. Centers for Disease Control and Prevention. 2023. "CDC Recommends a Powerful New Tool to Protect Infants from the Leading Cause of Hospitalization." cdc.gov. August 3. https://www.cdc.gov/media/releases/2023/p-0803-new-tool-prevent-infant-hospitalization-.html
  253. Hedley K et al. "Alterations in Brainstem Respiratory Centers following Peripheral Inflammation: A systematic review." Journal of Neuroimmunology 2022;369:577903. Hoogland ICM et al. "Systemic Inflammation and Microglial Activation: Systematic review of Animal Experiments." Journal of Neuroinflammation 2015;12, article number 114.
  254. Miller, Neil Z. 2021. "Vaccines and Sudden Infant Death: An Analysis of the VAERS Database 1990–2019 and Review of the Medical Literature." Toxicology Reports 8: 1324–1335. https://doi.org/10.1016/j.toxrep.2021.06.020
  255. Miller, Neil Z. 2021. "Vaccines and Sudden Infant Death: An Analysis of the VAERS Database 1990–2019 and Review of the Medical Literature." Toxicology Reports 8: 1324–1335. https://doi.org/10.1016/j.toxrep.2021.06.020
    1. "GlaxoSmithKline Confidential Clinical Study Final Report: Study 113808 (ROTA-075)." October 29. https://s3.amazonaws.com/ctr-gsk-7381/113808/5056b56b-5311-466e-9f63-d1b647b37b89/321842cb-a46c-4e78-9154-e1773829baa7/gsk-113808-clinical-study-report-redact-v1.pdf
  257. Lazarus, Ross. 2010. Electronic Support for Public Health—Vaccine Adverse Event Reporting System (ESP:VAERS). Grant Final Report, The Agency for Healthcare Research and Quality (AHRQ) U.S. Department of Health and Human Services, Boston: Harvard Pilgrim Health Care, Inc. https://digital.ahrq.gov/ahrq-funded-projects/electronic-support-public-health-vaccine-adverse-event-reporting-system
  258. Centers for Disease Control and Prevention. Division of Reproductive Health. 2023. "Maternal and Infant Health: Infant Mortality." cdc.gov. September 13. https://www.cdc.gov/reproductivehealth/maternalinfanthealth/infantmortality.htm
  259. Ram M, Shoenfeld Y. "Hepatitis B: Infection, Vaccination and Autoimmunity." 2008; The Israel Medical Association Journal 10: 61–64.
    1. "Judicial Notice: Numerical Risk Comparison of Non-vaccination Versus Vaccination." vaxcheckers.org. September. https://vaxcheckers.org/wp-content/uploads/2021/09/PRJN4.pdf
  261. Centers for Disease Control and Prevention. 2021. "Chapter 7 Diphtheria." In Epidemiology and Prevention of Vaccine-Preventable Diseases 14th ed. (The Pink Book), edited by Anna M. Acosta, Pedro L. Moro, Susan Hariri and Tejpratap S.P. Tiwari. Washington, D.C.: Public Health Foundation. https://www.cdc.gov/vaccines/pubs/pinkbook/downloads/dip.pdf
  262. Humphries MD, Suzanne, and Roman Bystrianyk. 2013. Dissolving Illusions: Disease, Vaccines, and the Forgotten History. CreateSpace Independent Publishing Platform.
  263. College of Physicians of Philadelphia. 2022. "History of Diphtheria." History of Vaccines. April 9. https://historyofvaccines.org/history/diphtheria/overview
  264. Centers for Disease Control and Prevention. 2015. "Chapter 7: Diphtheria." In Epidemiology and Prevention of Vaccine-Preventable Diseases 13th ed. (The Pink Book), edited by Jennifer Hamborsky, Andrew Kroger and Charles Wolfe, 107–118. Washington, D.C.: Public Health Foundation.
  265. Centers for Disease Control and Prevention. n.d. "Morbidity and Mortality Weekly Report (MMWR): Summary of Notifiable Infectious Diseases." cdc.gov. Accessed April 30, 2024. https://www.cdc.gov/mmwr/mmwr_nd/index.html
  266. Centers for Disease Control and Prevention. 1996. "Chapter 16: Tetanus." In Manual for the Surveillance of Vaccine-Preventable Diseases, by Amy Blain and Tejpratap S. P. Tiwari. Atlanta, GA: National Center for Immunization and Respiratory Diseases. https://www.cdc.gov/vaccines/pubs/surv-manual/chpt16-tetanus.html
  267. Long, G. H., A. T. Karanikas, E. T. Harvill, A. F. Read, and P. J. Hudson. 2010. "Acellular Pertussis Vaccination Facilitates Bordetella Parapertussis Infection in a Rodent Model of Bordetellosis." Proceedings of the Royal Society of Biological Sciences 277 (1690): 2017–2025. https://doi.org/10.1098%2Frspb.2010.0010
  268. Ma, L., A. Caulfield, K. K. Dewan, and E. T. Harvill. 2021. "Pertactin-Deficient Bordetella Pertussis, Vaccine-Driven Evolution, and Reemergence of Pertussis." Emerging Infectious Diseases 27 (6): 1561–1566. https://doi.org/10.3201/eid2706.203850
  269. Grove, Robert D., and Alice M. Hetzel. 1968. "Vital Statistics Rates in the United States: 1940–1960." cdc.gov National Center for Health Statistics. https://www.cdc.gov/nchs/data/vsus/vsrates1940_60.pdf
  270. Centers for Disease Control and Prevention. 2022. "Surveillance & Reporting: Pertussis Cases by Year (1922–2021)." cdc.gov. August 4. https://www.cdc.gov/pertussis/surv-reporting/cases-by-year.html
    1. "Judicial Notice: Numerical Risk Comparison of Non-vaccination Versus Vaccination." vaxcheckers.org. September. https://vaxcheckers.org/wp-content/uploads/2021/09/PRJN4.pdf
  272. Humphries MD, Suzanne, and Roman Bystrianyk. 2013. Dissolving Illusions: Disease, Vaccines, and the Forgotten History. CreateSpace Independent Publishing Platform.
  273. Mehndiratta, M. M., P. Mehndiratta, and Pande R. 2014. "Poliomyelitis: Historical Facts, Epidemiology, and Current Challenges in Eradication." Neurohospitalist 4 (4): 223–229. https://doi.org/10.1177/1941874414533352
  274. Centers for Disease Control and Prevention. 2009. Epidemiology and Prevention of Vaccine-Preventable Diseases 11th ed. (The Pink Book). Edited by W. Atkinson, S. Wolfe, J. Hamborsky and L. McIntyre. Washington, D.C.: Public Health Foundation.
  275. Centers for Disease Control and Prevention. 2021. "Chapter 18 Poliomyelitis." In Epidemiology and Prevention of Vaccine-Preventable Diseases 14th ed. (The Pink Book), edited by E. Hall, A. P. Wodi, J. Hamborsky, V. Morelli and S. Schillie, 276. Washington, D.C.: Public Health Foundation. https://www.cdc.gov/vaccines/pubs/pinkbook/downloads/polio.pdf
  276. Centers for Disease Control and Prevention. 2023. "What is Polio?" cdc.gov. January 9. https://www.cdc.gov/polio/what-is-polio/index.htm
  277. Magno, Hector, and Beatrice Golomb. 2020. "Measuring the Benefits of Mass Vaccination Programs in the United States." Vaccines 8 (4): 561. https://doi.org/10.3390%2Fvaccines8040561
    1. "Physicians for Informed Consent Polio: Vaccine Risk Statement (VRS)." Physicians for Informed Consent. August. https://physiciansforinformedconsent.org/polio-vrs/
  279. Magno, Hector, and Beatrice Golomb. 2020. "Measuring the Benefits of Mass Vaccination Programs in the United States." Vaccines 8 (4): 561. https://doi.org/10.3390%2Fvaccines8040561
  280. Centers for Disease Control and Prevention. 2009. Epidemiology and Prevention of Vaccine-Preventable Diseases 11th ed. (The Pink Book). Edited by W. Atkinson, S. Wolfe, J. Hamborsky and L. McIntyre. Washington, D.C.: Public Health Foundation.
  281. Centers for Disease Control and Prevention. 2021. "Chapter 18 Poliomyelitis." In Epidemiology and Prevention of Vaccine-Preventable Diseases 14th ed. (The Pink Book), edited by E. Hall, A. P. Wodi, J. Hamborsky, V. Morelli and S. Schillie, 276. Washington, D.C.: Public Health Foundation. https://www.cdc.gov/vaccines/pubs/pinkbook/downloads/polio.pdf
  282. Centers for Disease Control and Prevention. 2023. "What is Polio?" cdc.gov. January 9. https://www.cdc.gov/polio/what-is-polio/index.htm
  283. Sanofi Pasteur. 2022. "Package Insert: IPOL®, Poliovirus Vaccine Inactivated." fda.gov. May. https://www.fda.gov/media/75695/download
    1. "Physicians for Informed Consent Polio: Vaccine Risk Statement (VRS)." Physicians for Informed Consent. August. https://physiciansforinformedconsent.org/polio-vrs/
    1. "VAERS Data." Vaccine Adverse Event Reporting System (VAERS) on HHS.gov. https://vaers.hhs.gov/data.html
  286. Bisgard, Kristine M., Annie S. Kao, John Leake, Peter M. Strebel, Bradley A. Perkins, and Melinda Wharton. 1998. "Haemophilus Influenzae Invasive Disease in the United States, 1994–1995: Near Disappearance of a Vaccine-Preventable Childhood Disease." Emerging Infectious Diseases 4 (2): 229–237. https://pubmed.ncbi.nlm.nih.gov/9621193/
  287. Bisgard, Kristine M., Annie S. Kao, John Leake, Peter M. Strebel, Bradley A. Perkins, and Melinda Wharton. 1998. "Haemophilus Influenzae Invasive Disease in the United States, 1994–1995: Near Disappearance of a Vaccine-Preventable Childhood Disease." Emerging Infectious Diseases 4 (2): 229–237. https://pubmed.ncbi.nlm.nih.gov/9621193/
  288. Bruce, Michael G., Tammy Zulz, Carolynn DeByle, Ros Singleton, Debby Hurlburt, Dana Bruden, Karen Rudolph, Thomas Hennessy, Joseph Klejka, and Jay D. Wenger. 2013. "Haemophilus influenzae Serotype A Invasive Disease, Alaska, USA, 1983–2011." Emerging Infectious Diseases 19 (6): 932–937. https://pubmed.ncbi.nlm.nih.gov/23735653/
  289. Ribeiro, G. S., J. N. Reis, S. M. Cordeiro, J. B. Lima, E. L. Gouveia, M. Petersen, K. Salgado, et al. 2003. "Prevention of Haemophilus Influenzae Type B (Hib) Meningitis and Emergence of Serotype Replacement with Type A Strains after Introduction of Hib Immunization in Brazil." The Journal of Infectious Diseases 187 (1): 109–116. https://doi.org/10.1086/345863
  290. Adam, H. J., S. E. Richardson, F. B. Jamieson, P. Rawte, D. E. Low, and D. N. Fisman. 2010. "Changing Epidemiology of Invasive Haemophilus Influenzae in Ontario, Canada: Evidence for Herd Effects and Strain Replacement Due to Hib Vaccination." Vaccine 28 (24): 4073–4078. https://www.sciencedirect.com/science/article/abs/pii/S0264410X10004755
  291. Sadeghi-Aval, Pouya, Raymond S.W. Tsang, Frances B. Jamieson, and Marina Ulanova. 2013. "Emergence of Non-Serotype b Encapsulated Haemophilus Influenzae as a Cause of Pediatric Meningitis in Northwestern Ontario." Canadian Journal of Infectious Diseases and Medical Microbiology 24 (1): 13–16. https://doi.org/10.1155%2F2013%2F828730
  292. Classen, John B., and David C. Classen. 2002. "Clustering of Cases of Insulin Dependent Diabetes (IDDM) Occurring Three Years after Hemophilus Influenza B (HiB) Immunization Support Causal Relationship between Immunization and IDDM." Autoimmunity 35 (4): 247–253. https://www.tandfonline.com/doi/abs/10.1080/08916930290028175
  293. Wahlberg, J., J. Fredriksson, O. Vaarala, J. Ludvigsson, and Abis Study Group. 2003. "Vaccinations May Induce Diabetes-Related Autoantibodies in One-Year-Old Children." Annals of the New York Academy of Sciences 1005 (1): 404–408. https://doi.org/10.1196/annals.1288.068
  294. Classen, John B., and David C. Classen. 1999. "Public Should Be Told That Vaccines May Have Long Term Adverse Effects." BMJ 318 (7177): 193. https://www.bmj.com/content/318/7177/193.1
  295. Classen, John B., and David C. Classen. 1999. "Association between Type 1 Diabetes and Hib Vaccine. Causal Relation is Likely." BMJ 319 (7217): 1133. https://www.bmj.com/content/319/7217/1133.1
    1. "VAERS Data." Vaccine Adverse Event Reporting System (VAERS) on HHS.gov. https://vaers.hhs.gov/data.html
  297. Centers for Disease Control and Prevention. 2021. "Vaccine Information Statement: Rotavirus Vaccine—What You Need to Know." cdc.gov. October 15. https://www.cdc.gov/vaccines/hcp/vis/vis-statements/rotavirus.pdf
  298. Ruiz-Palacios, Guillermo M., I. Pérez-Schael, F. Velázquez, H. Abate, Human Rotavirus Vaccine Study Group, et al. 2006. "Safety and Efficacy of an Attenuated Vaccine against Severe Rotavirus Gastroenteritis." The New England Journal of Medicine 354 (1): 11–22. https://doi.org/10.1056/nejmoa052434
  299. Vesikari, Timo, David O. Matson, Penelope Dennehy, Pierre Van Damme, Mathuram Santosham, Zoe Rodriguez, et al., and for the Rotavirus Efficacy and Safety Trial (REST). 2006. "Safety and Efficacy of a Pentavalent Human–Bovine (WC3) Reassortant Rotavirus Vaccine." The New England Journal of Medicine 354: 23–33. https://doi.org/10.1056/NEJMoa052664
  300. Hooker, Brian, J. Kern, D. Geier, B. Haley, L. Sykes, P King, and M. Geier. 2014. "Methodological Issues and Evidence of Malfeasance in Research Purporting to Show Thimerosal in Vaccines Is Safe." BioMed Research International. https://doi.org/10.1155%2F2014%2F247218
  301. Sharpe, Martyn A., Andrew D. Livingston, and David S. Baskin. 2012. "Thimerosal-Derived Ethylmercury Is a Mitochondrial Toxin in Human Astrocytes: Possible Role of Fenton Chemistry in the Oxidation and Breakage of mtDNA." Journal of Toxicology 2012. https://doi.org/10.1155/2012/373678
  302. Barregard, Lars, Dinko Rekić, Milena Horvat, Lisa Elmberg, Thomas Lundh, and Olof Zachrisson. 2011. "Toxicokinetics of Mercury after Long-term Repeated Exposure to Thimerosal-containing Vaccine." Toxicological Sciences 120 (2): 499–506. https://academic.oup.com/toxsci/article/120/2/499/1670799
  303. Bragadin, Marcantonio, Daniele Marton, Sabrina Manente, Mario Grasso, and Antonio Toninello. 2002. "Methylmercury Induces the Opening of the Permeability Transition Pore in Rat Liver Mitochondria." Journal of Inorganic Biochemistry 89 (1-2): 159–162. https://pubmed.ncbi.nlm.nih.gov/11931977/
  304. Canty, A. J., P. W. Moors, and G. B. Deacon. 1984. "Octanol/Water Partition Coefficients as a Model System for Assessing Antidotes for Methylmercury (II) Poisoning, and for Studying Mercurials with Medicinal Applications." Journal of Inorganic Biochemistry 22 (1): 65–72. https://www.sciencedirect.com/science/article/abs/pii/0162013484850643
  305. Yin, Zhaobao, Eunsook Lee, Mingwei Ni, Haiyan Jiang, Dejan Milatovic, Lu Rongzhu, Marcelo Farina, Joao B.T. Rocha, and Michael Aschner. 2011. "Methylmercury-induced Alterations in Astrocyte Functions Are Attenuated by Ebselen." NeuroToxicology 32 (3): 291–299. https://doi.org/10.1016/j.neuro.2011.01.004
  306. Kirby, David. 2006. Evidence of Harm: Mercury in Vaccines and the Autism Epidemic: A Medical Controversy. St. Martin's Griffin.
  307. Centers for Disease Control and Prevention. 2024. "CDC Seasonal Flu Vaccine Effectiveness Studies." cdc.gov. February 29. https://www.cdc.gov/flu/vaccines-work/effectiveness-studies.htm
  308. Bodewes, Rogier, Joost H.C.M. Kreijtz, and Guus F. Rimmelzwaan. 2009. "Yearly Influenza Vaccinations: A Double-edged Sword?" The Lancet Infectious Diseases 9 (12): 784–788. https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(09)70263-4/abstract
  309. Donahue, James G., Burney A. Kieke, Jennifer P. King, Frank DeStefano, Maria A. Mascola, et al. 2017. "Association of Spontaneous Abortion with Receipt of Inactivated Influenza Vaccine Containing H1N1pdm09 in 2010-11 and 2011-12." Vaccine 35 (40): 5314–5322. https://doi.org/10.1016/j.vaccine.2017.06.069
  310. Sencer, David J., and J. Donald Millar. 2006. "Reflections on the 1976 Swine Flu Vaccination Program." Emerging Infectious Diseases 12 (1): 29–33. https://doi.org/10.3201%2Feid1201.051007
    1. "VAERS Data." Vaccine Adverse Event Reporting System (VAERS) on HHS.gov. https://vaers.hhs.gov/data.html
    1. "Institute for Vaccine Safety: Package Inserts and Manufacturers for Some US Licensed Vaccines and Immunoglobulins." October 27. https://www.vaccinesafety.edu/package-inserts-and-manufacturers-for-some-us-licensed-vaccines-and-immunoglobulins/
  313. Hayward, Andrew C., Ellen B. Fragaszy, Alison Bermingham, Lili Wang, Andrew Copas, et al. 2014. "Comparative Community Burden and Severity of Seasonal and Pandemic Influenza: Results of the Flu Watch Cohort Study." The Lancet Respiratory Medicine 2 (6): 445–454. https://doi.org/10.1016/S2213-2600(14)70034-7
  314. Centers for Disease Control and Prevention. "Pneumonia and Influenza Mortality Surveillance from the National Center for Health Statistics Mortality Surveillance System." cdc.gov. Accessed 2024. https://gis.cdc.gov/grasp/fluview/mortality.html
    1. "SARS CoV Patent Corpus Literature Review." M·CAM International LLC. April. https://www.m-cam.com/wp-content/uploads/2020/04/20200403_SARS_CoV_Patent_Corpus_Lit_Review.pdf
  316. Mansanguan, S., P. Charunwatthana, et al. 2022. "Cardiovascular Manifestation of the BNT162b2 mRNA COVID-19 Vaccine in Adolescents." Tropical Medicine and Infectious Disease 7 (8): 196. https://doi.org/10.3390/tropicalmed7080196
  317. Seneff, Stephanie, Greg Nigh, Anthony M. Kyriakopoulos, and Peter A. McCullough. 2022. "Innate Immune Suppression by SARS-CoV-2 mRNA Vaccinations: The Role of G-quadruplexes, Exosomes, and MicroRNAs." Food and Chemical Toxicology 164. https://doi.org/10.1016/j.fct.2022.113008
  318. Polykretis, Panagis, Alberto Donzelli, Janci C. Lindsay, David Wiseman, et al. 2023. "Autoimmune Inflammatory Reactions Triggered by the COVID-19 Genetic Vaccines in Terminally Differentiated Tissues." Autoimmunity 56 (1). https://doi.org/10.1080/08916934.2023.2259123
  319. Rapkiewicza, Amy V., Xingchen Mai, Steven E. Carsons, Stefania Pittalugac, et al. 2020. "Megakaryocytes and Platelet-fibrin Thrombi Characterize Multi-Organ Thrombosis at Autopsy in COVID-19: A Case Series." EClinicalMedicine 24. https://doi.org/10.1016%2Fj.eclinm.2020.100434
  320. Kory, Pierre. 2023. "Our Reply to the American Board of Internal Medicine." Pierre Kory's Medical Musings on Substack. August 5. https://pierrekorymedicalmusings.com/p/our-reply-to-the-american-board-of
  321. King, William W., et al. 2021. "Myocarditis Following mRNA Vaccination Against SARS-CoV-2, a Case Series." American Heart Journal Plus: Cardiology Research and Practice 8. https://doi.org/10.1016/j.ahjo.2021.100042
  322. Montgomery, Jay, Margaret Ryan, Renata Engler, et al. 2021. "Myocarditis Following Immunization With mRNA COVID-19 Vaccines in Members of the US Military." JAMA Cardiology 6 (10): 1202–1206. https://doi.org/10.1001/jamacardio.2021.2833
  323. Dionne, Audrey, Francesca Sperotto, Stephanie Chamberlain, et al. 2021. "Association of Myocarditis with BNT162b2 Messenger RNA COVID-19 Vaccine in a Case Series of Children." JAMA Cardiology 6 (12): 1446–1450. https://doi.org/10.1001/jamacardio.2021.3471
  324. Marshall MD, Mayme, Ian D. Ferguson, et al. 2021. "Symptomatic Acute Myocarditis in 7 Adolescents after Pfizer-BioNTech COVID-19 Vaccination." Pediatrics 148 (3). https://doi.org/10.1542/peds.2021-052478
  325. Luk MD, Adriana, et al. 2021. "Myocarditis and Pericarditis After COVID-19 mRNA Vaccination: Practical Considerations for Care Providers." Canadian Journal of Cardiology 37 (10): 1629–1634. https://doi.org/10.1016/j.cjca.2021.08.001
  326. Pepe, Salvatore, Ann T. Gregory, A. Robert Denniss, et al. 2021. "Myocarditis, Pericarditis and Cardiomyopathy after COVID-19 Vaccination." Heart, Lung and Circulation 30 (10): 1425–1429. https://doi.org/10.1016/j.hlc.2021.07.011
  327. Bozkurt, Biykem, Ishan Kamat, and Peter J. Hotez. 2021. "Myocarditis with COVID-19 mRNA Vaccines." Circulation 144 (6): 471–484. https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.121.056135
  328. Diaz, George A., Guilford T. Parsons, Sara K. Gering, et al. 2021. "Myocarditis and Pericarditis after Vaccination for COVID-19." JAMA 326 (12): 1210–1212. https://jamanetwork.com/journals/jama/fullarticle/2782900
  329. Rosner, Carolyn M., et al. 2021. "Myocarditis Temporally Associated with COVID-19 Vaccination." Circulation 144 (6). https://doi.org/10.1161/CIRCULATIONAHA.121.055891
  330. Jain, Supriya S., et al. 2021. "COVID-19 Vaccination–Associated Myocarditis in Adolescents." Pediatrics 148 (5). https://pediatrics.aappublications.org/content/pediatrics/early/2021/08/12/peds.2021-053427.full.pdf
  331. García, Javier Bautista, et al. 2021. "Acute Myocarditis after Administration of the BNT162b2 Vaccine against COVID-19." Revista Espanola de Cardiologia (English Edition) 74 (9): 802–814. https://doi.org/10.1016/j.rec.2021.04.005
  332. Sulemankhil, Imran, et al. 2022. "Temporal Association between the COVID-19 Ad26.COV2.S Vaccine and Acute Myocarditis: A Case Report and Literature Review." Cardiovascular Revascularization Medicine 38: 117–123. https://doi.org/10.1016/j.carrev.2021.08.012
  333. Nassar, Mahmoud, et al. 2021. "COVID-19 Vaccine-induced Myocarditis: Case Report with Literature Review." Diabetes & Metabolic Syndrome: Clinical Research & Reviews 15 (5). https://doi.org/10.1016/j.dsx.2021.102205
  334. Shaw MD, Kirsten E., et al. 2021. "Possible Association Between COVID-19 Vaccine and Myocarditis: Clinical and CMR Findings." JACC: Cardiovascular Imaging 14 (9): 1856–1861. https://doi.org/10.1016/j.jcmg.2021.06.002
  335. Minocha, Prashant K., et al. 2021. "Recurrence of Acute Myocarditis Temporally Associated with Receipt of the mRNA Coronavirus Disease 2019 (COVID-19) Vaccine in a Male Adolescent." The Journal of Pediatrics 238: 321–323. https://doi.org/10.1016/j.jpeds.2021.06.035
  336. Abbate, Antonio, et al. 2021. "Fulminant Myocarditis and Systemic Hyperinflammation Temporally Associated with BNT162b2 mRNA COVID-19 Vaccination in Two Patients." International Journal of Cardiology 340: 119–121. https://www.sciencedirect.com/science/article/pii/S0167527321012286
  337. Habib, Mhd Baraa, et al. 2021. "Acute Myocarditis following Administration of BNT162b2 Vaccine." IDCases 25. https://doi.org/10.1016/j.idcr.2021.e01197
  338. Williams, Curtis B., Jung-in Choi, et al. 2021. "Acute Myocarditis following mRNA-1273 SARS-CoV-2 Vaccination." CJC Open 3 (11): 1410–1412. https://doi.org/10.1016/j.cjco.2021.07.008
  339. Dickey, John B., Elisabeth Albert, Mai Badr, et al. 2021. "A Series of Patients with Myocarditis following SARS-CoV-2 Vaccination With mRNA-1279 and BNT162b2." JACC: Cardiovascular Imaging 14 (9): 1862–1863. https://doi.org/10.1016/j.jcmg.2021.06.003
  340. Singh, Balraj, et al. 2021. "COVID-19 mRNA Vaccine and Myocarditis." European Journal of Case Reports in Internal Medicine 8 (6). https://doi.org/10.12890/2021_002681
  341. Salah, Husam M., and Jawahar L. Mehta. 2021. "COVID-19 Vaccine and Myocarditis." American Journal of Cardiology 157: 146–148. https://doi.org/10.1016/j.amjcard.2021.07.009
  342. Park, Hwanhee, et al. 2021. "Epidemiology and Clinical Features of Myocarditis/Pericarditis before the Introduction of mRNA COVID-19 Vaccine in Korean Children: A Multicenter Study." Journal of Korean Medical Science 36 (32). https://doi.org/10.3346%2Fjkms.2021.36.e232
  343. Kerneis, Mathieu, et al. 2021. "COVID-19 Vaccines and Myocarditis." Archives of Cardiovascular Diseases 114 (6-7): 515–517. https://doi.org/10.1016/j.acvd.2021.06.001
  344. Vidula, Mahesh K., et al. 2021. "Myocarditis and Other Cardiovascular Complications of the mRNA-Based COVID-19 Vaccines." Cureus 13 (6). https://doi.org/10.7759/cureus.15576
  345. Pepe, Salvatore, Ann T. Gregory, A. Robert Denniss, et al. 2021. "Myocarditis, Pericarditis and Cardiomyopathy After COVID-19 Vaccination." Heart, Lung and Circulation 30 (10): 1425–1429. https://doi.org/10.1016/j.hlc.2021.07.011
  346. Bozkurt, Biykem, Ishan Kamat, and Peter J. Hotez. 2021. "Myocarditis With COVID-19 mRNA Vaccines." Circulation 144 (6): 471–484. https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.121.056135
    1. "Association of Myocarditis with mRNA COVID-19 Vaccine in Children." JAMA Cardiology. https://media.jamanetwork.com/news-item/association-of-myocarditis-with-mrna-covid-19-vaccine-in-children/
  348. Dionne, Audrey, Francesca Sperotto, Stephanie Chamberlain, et al. 2021. "Association of Myocarditis with BNT162b2 Messenger RNA COVID-19 Vaccine in a Case Series of Children." JAMA Cardiology 6 (12): 1446–1450. https://doi.org/10.1001/jamacardio.2021.3471
  349. Shay, David K., T. T. Shimabukuro, and F. DeStefano. 2021. "Myocarditis Occurring After Immunization With mRNA-Based COVID-19 Vaccines." JAMA Cardiology 6 (10): 1115–1117. https://doi.org/10.1001/jamacardio.2021.2821
  350. Verma MD, Amanda K., et al. 2021. "Myocarditis after Covid-19 mRNA Vaccination." The New England Journal of Medicine 385: 1332–1334. https://doi.org/10.1056/NEJMc2109975
  351. Kim, Han W., Elizabeth R. Jenista, et al. 2021. "Patients with Acute Myocarditis following mRNA COVID-19 Vaccination." JAMA Cardiology 6 (10): 1196–1201. https://jamanetwork.com/journals/jamacardiology/fullarticle/2781602
  352. Starekova, Jitka, et al. 2021. "Myocarditis Associated with mRNA COVID-19 Vaccination." Radiology 301 (2). https://doi.org/10.1148/radiol.2021211430
  353. Wong, Peter D., et al. 2021. "Clinical Guidance for Youth with Myocarditis and Pericarditis Following mRNA COVID-19 Vaccination." Canadian Paediatric Society. September 1. https://cps.ca/en/documents/position/clinical-guidance-for-youth-with-myocarditis-and-pericarditis
    1. "COVID-19 Vaccine-associated Myocarditis/Pericarditis: A Report of the Chief Science Advisor of Canada." Office of the Chief Science Advisor of Canada. July 16. https://science.gc.ca/site/science/en/office-chief-science-advisor/covid-19-vaccine-associated-myocarditispericarditis
  355. Viskin, Dana, et al. 2021. "Myocarditis Associated with COVID-19 Vaccination: Echocardiography, Cardiac Tomography, and Magnetic Resonance Imaging Findings." Circulation: Cardiovascular Imaging 14 (9). https://doi.org/10.1161/CIRCIMAGING.121.013236
    1. "Physicians for Informed Consent COVID-19 Vaccine Mandates: 21 Scientific Facts That Challenge the Assumptions, Vaccine Risk Statement (VRS)." Physicians for Informed Consent. November. https://physiciansforinformedconsent.org/COVID-19-Vaccine-Mandates.pdf
  357. Shitrit, P., N. S. Zuckerman, O. Mor, B. S. Gottesman, and M. Chowers. 2021. "Nosocomial Outbreak Caused by the SARS-CoV-2 Delta Variant in a Highly Vaccinated Population, Israel, July 2021." Euro Surveillance 26 (39). https://doi.org/10.2807/1560-7917.es.2021.26.39.2100822
  358. Brown, C.M., et al. 2021. "Outbreak of SARS-CoV-2 Infections, Including COVID-19 Vaccine Breakthrough Infections, Associated with Large Public Gatherings—Barnstable County, Massachusetts, July 2021." MMWR: Recommendations and Reports 70 (31): 1059–1062. https://www.cdc.gov/mmwr/volumes/70/wr/mm7031e2.htm
  359. Subramanian, S. V., and A. Kumar. 2021. "Increases in COVID-19 Are Unrelated to Levels of Vaccination Across 68 Countries and 2947 Counties in the United States." European Journal of Epidemiology 36: 1237–1240. https://doi.org/10.1007/s10654-021-00808-7
    1. "FDA Briefing Document: Moderna COVID-19 Vaccine." fda.gov. December 17. https://www.fda.gov/media/144434/download
    1. "FDA Briefing Document: Janssen Ad26.COV2.S Vaccine for the Prevention of COVID-19." fda.gov. February 26. https://www.fda.gov/media/146217/download
    1. "FDA Briefing Document: Pfizer-BioNTech COVID-19 Vaccine." fda.gov. December 10. https://www.fda.gov/media/144245/download
  363. Centers for Disease Control and Prevention. 2024. "COVID Data Tracker: Trends in Number of COVID-19 Cases and Deaths in the US Reported to CDC, By State/Territory." cdc.gov. https://covid.cdc.gov/covid-data-tracker/#trends_totaldeaths
  364. Fraiman, J., et al. 2022. "Serious Adverse Events of Special Interest following mRNA COVID-19 Vaccination in Randomized Trials in Adults." Vaccine (2022) 40 (40): 5798–805. https://doi.org/10.1016/j.vaccine.2022.08.036
    1. "Pfizer-BioNTech COVID-19 Vaccine: Emergency Use Authorization (EUA) Amendment for an Unapproved Product Review Memorandum—EUA 27034 (Amendment 132)." fda.gov. April 9. https://www.fda.gov/media/148542/download
    1. "FDA Briefing Document: EUA Amendment Request for Pfizer-BioNTech COVID-19 Vaccine for Use in Children 5 through 11 Years of Age." fda.gov. October 26. https://www.fda.gov/media/153447/download
  367. Wallace, Megan. 2021. "ACIP COVID-19 Vaccines Work Group: Grading of Recommendations, Assessment, Development, and Evaluation (GRADE): Pfizer-BioNTech COVID-19 Vaccine." cdc.gov. May 12. https://www.cdc.gov/vaccines/acip/meetings/downloads/slides-2021-05-12/03-COVID-Wallace-508.pdf
  368. Centers for Disease Control and Prevention. 2021. "Grading of Recommendations, Assessment, Development, and Evaluation (GRADE): Pfizer-BioNTech COVID-19 Vaccine for Persons Aged 12–15 Years." cdc.gov. May 14. https://www.cdc.gov/vaccines/acip/recs/grade/covid-19-pfizer-biontech-vaccine-12-15-years.html#table03d
  369. Pfizer. 2023. "Downloadable Archived Fact Sheets for Healthcare Providers, Recipients and Caregivers for Pfizer-BioNTech COVID-19 Vaccine (through Summer 2023)." fda.gov. https://www.fda.gov/media/167193/download
    1. "Physicians for Informed Consent Education: COVID-19 Vaccines." Physicians for Informed Consent. https://physiciansforinformedconsent.org/covid-19-vaccines/
  371. Centers for Disease Control and Prevention. 2023. "Weekly Updates by Select Demographic and Geographic Characteristics: Provisional Death Counts for Coronavirus Disease (COVID-19)." cdc.gov. September 27. https://www.cdc.gov/nchs/nvss/vsrr/covid_weekly/index.htm#AgeAndSex
  372. Petersen, Maria Skaalum, Cecilie Bo Hansen, Marnar Fríheim Kristiansen, Jógvan Páll Fjallsbak, et al. 2021. "SARS-CoV-2 Natural Antibody Response Persists for at Least 12 Months in a Nationwide Study from the Faroe Islands." Open Forum Infectious Diseases 8 (8). https://doi.org/10.1093/ofid/ofab378
  373. Haveri, Anu, Nina Ekström, Anna Solastie, Camilla Virta, et al. 2021. "Persistence of Neutralizing Antibodies a Year after SARS-CoV-2 Infection in Humans." European Journal of Immunology 51 (12): 3202–3213. https://doi.org/10.1002/eji.202149535
  374. Zhang, Jie, Hao Lin, Beiwei Ye, Min Zhao, et al. 2022. "One-Year Sustained Cellular and Humoral Immunities in Coronavirus Disease 2019 (COVID-19) Convalescents." Clinical Infectious Diseases 75 (1): 1072–1081. https://doi.org/10.1093/cid/ciab884
  375. Canaday, David H., Oladayo A. Oyebanji, Debbie Keresztesy, Michael Payne, et al. 2022. "Significant Reduction in Vaccine-Induced Antibody Levels and Neutralization Activity Among Healthcare Workers and Nursing Home Residents 6 Months Following Coronavirus Disease 2019 BNT162b2 mRNA Vaccination." Clinical Infectious Diseases 75 (1): 884–887. https://academic.oup.com/cid/article/75/1/e884/6432026
  376. Suthar, Mehul S., Prabhu S. Arunachalam, Mengyun Hu, Noah Reis, et al. 2022. "Durability of Immune Responses to the BNT162b2 mRNA Vaccine." Med 3 (1): 25–27. https://doi.org/10.1016/j.medj.2021.12.005
  377. Doria-Rose, Nicole, Mehul S. Suthar, et al. 2021. "Antibody Persistence through 6 Months after the Second Dose of mRNA-1273 Vaccine for Covid-19." The New England Journal of Medicine 384 (23): 2259–2261. https://doi.org/10.1056/nejmc2103916
  378. Cohen, Kristen W., Susanne L. Linderman, Zoe Moodie, et al. 2021. "Longitudinal Analysis Shows Durable and Broad Immune Memory after SARS-CoV-2 Infection with Persisting Antibody Responses and Memory B and T Cells." Cell Reports Medicine 2 (7). https://doi.org/10.1016/j.xcrm.2021.100354
  379. Hammond, Jeremy R. 2021. "Antibodies Persist with Natural Immunity to SARS-CoV-2." Jeremy R. Hammond. October 11. https://www.jeremyrhammond.com/2021/10/11/antibodies-persist-with-natural-immunity-to-sars-cov-2/
  380. Israel, Ariel, Yotam Shenhar, Ilan Green, Eugene Merzon, et al. 2022. "Large-Scale Study of Antibody Titer Decay following BNT162b2 mRNA Vaccine or SARS-CoV-2 Infection." Vaccines 10 (1): 64. https://doi.org/10.3390/vaccines10010064
  381. Eyran, Tsuf, Anna Vaisman-Mentesh, David Taussig, et al. 2022. "Longitudinal Kinetics of RBD+ Antibodies in COVID-19 Recovered Patients over 14 Months." PLoS Pathogens 18 (6). https://doi.org/10.1371/journal.ppat.1010569
  382. Aldén, Markus, Francisko Olofsson Falla, Daowei Yang, Mohammad Barghouth, et al. 2022. "Intracellular Reverse Transcription of Pfizer BioNTech COVID-19 mRNA Vaccine BNT162b2 In Vitro in Human Liver Cell Line." Current Issues in Molecular Biology 44 (3): 1115–1126. https://www.mdpi.com/1467-3045/44/3/73
  383. WBALTV11. 2015. "Possible Measles Case in a 12-month-old from Baltimore Health: Officials Taking Precaution." January 24. https://www.wbaltv.com/article/possible-measles-case-in-a-12-month-old-from-baltimore/7091459
  384. Hendriks, Jan, and Stuart Blume. 2013. "Measles Vaccination before the Measles-Mumps-Rubella Vaccine." American Journal of Public Health (AJPH) 103 (8): 1393–1401. https://doi.org/10.2105/AJPH.2012.301075
  385. Langmuir, Alexander D., et al. 1962. "The Importance of Measles as a Health Problem." American Journal of Public Health (AJPH) 52 (Suppl 2): 1–4. https://doi.org/10.2105/ajph.52.suppl_2.1
  386. Rowhani-Rahbar, Ali, Bruce Fireman, Edwin Lewis, et al. 2013. "Effect of Age on the Risk of Fever and Seizures following Immunization with Measles-Containing Vaccines in Children." JAMA Pediatrics 167 (12): 1111–1117. https://doi.org/10.1001/jamapediatrics.2013.2745
  387. Merck & Co., Inc. 2023. "Package Insert—M-M-R® II (Measles, Mumps, and Rubella Virus Vaccine Live)." fda.gov. https://www.fda.gov/media/75191/download
  388. Merck & Co., Inc. 2023. "Package Insert—M-M-R® II (Measles, Mumps, and Rubella Virus Vaccine Live)." fda.gov. https://www.fda.gov/media/75191/download
  389. Riazi, K., M. Galic, B. Kuzmiski, W. Ho, K. Sharkey, Q. Pittman. 2008. "Microglial Activation and TNFa Production Mediate Altered CNS Excitability following Peripheral Inflammation." Proceedings of the National Academy of Sciences of the United States of America. 8:2008; 105(44):17151–17156. Holzer, P., A. Farzi, A. M. Hassan, G. Zenz, A. Jačan, and F. Reichmann F. 2017. "Visceral Inflammation and Immune Activation Stress the Brain." Frontiers in Immunology. 2017 Nov 22;8:1613. doi: 10.3389/fimmu.2017.01613. Rodriguez Juan I., and Janet K. Kern. 2011. "Evidence of Microglial Activation in Autism and Its Possible Role in Brain Underconnectivity." Neuron Glia Biology 2011;7(2-4):205–213. doi:10.1017/S1740925X12000142.
    1. "August 27, 2014 Press Release, 'Statement of William W. Thompson, Ph.D., regarding the 2004 Article Examining the Possibility of a Relationship between MMR Vaccine and Autism'." legislature.vermont.gov. August 27. https://legislature.vermont.gov/Documents/2016/WorkGroups/House%20Health%20Care/Bills/H.98/Witness%20Testimony/H.98~Jennifer%20Stella~William%20Thompson%20Statement~5-6-2015.pdf
  391. Hooker, Brian S. 2014. "Measles-Mumps-Rubella Vaccination Timing and Autism Among Young African American Boys: A Reanalysis of CDC Data." Translational Neurodegeneration 3 (16). https://doi.org/10.1186/2047-9158-3-16
  392. Bigtree, Del, and Andrew Wakefield. 2016. VAXXED: From Cover-Up to Catastrophe. Directed by Andrew Wakefield. Produced by Del Bigtree and Polly Tommey. https://vaxxedthemovie.com/
  393. Merck & Co., Inc. 2023. "Package Insert—M-M-R® II (Measles, Mumps, and Rubella Virus Vaccine Live)." fda.gov. https://www.fda.gov/media/75191/download
    1. "VAERS Data." Vaccine Adverse Event Reporting System (VAERS) on HHS.gov. https://vaers.hhs.gov/data.html
  395. Centers for Disease Control and Prevention. 2024. "Measles Cases and Outbreaks." cdc.gov. February 23. https://www.cdc.gov/measles/cases-outbreaks.html
  396. Centers for Disease Control and Prevention. 2024. "Measles Cases and Outbreaks." cdc.gov. February 23. https://www.cdc.gov/measles/cases-outbreaks.html
    1. "Physicians for Informed Consent Measles: Disease Information Statement (DIS)." Physicians for Informed Consent. https://physiciansforinformedconsent.org/measles-disease-information-statement.pdf
  398. Barclay, A. J., A. Foster, and A. Sommer. 1987. "Vitamin A Supplements and Mortality Related to Measles: A Randomised Clinical Trial." British Medical Journal (Clinical research ed.) 294 (6567): 294–296. https://www.bmj.com/content/294/6567/294.abstract
  399. Wilson, Kumanan, Steven Hawken, Jeffrey C. Kwong, Shelley Deeks, et al. 2011. "Adverse Events following 12 and 18 Month Vaccinations: A Population-Based, Self-Controlled Case Series Analysis." PLoS One 6 (12). https://doi.org/10.1371/journal.pone.0027897
    1. "Mumps Clinical Information." Minnesota Department of Health. August 1. https://www.health.state.mn.us/diseases/mumps/hcp/clinical.html
  401. Deeks, Shelley L., Gillian H. Lim, Mary Anne Simpson, et al. 2011. "An Assessment of Mumps Vaccine Effectiveness by Dose During an Outbreak in Canada." Canadian Medical Association Journal 183 (9): 1014–1020. https://doi.org/10.1503/cmaj.101371
  402. Seck, Hope Hodge. 2019. "Navy Ship Changes Schedule after Outbreak of Mumps-Like Disease Aboard." Military.com, March 15. https://www.military.com/daily-news/2019/03/15/navy-ship-changes-schedule-after-outbreak-mumps-disease-aboard.html
  403. Dayan, Gustavo H., M. Patricia Quinlisk, Amy A. Parker, et al. 2008. "Recent Resurgence of Mumps in the United States." The New England Journal of Medicine 358: 1580–1589. https://doi.org/10.1056/nejmoa0706589
  404. Barskey, Albert E., Cynthia Schulte, Jennifer B. Rosen, et al. 2012. "Mumps Outbreak in Orthodox Jewish Communities in the United States." The New England Journal of Medicine 367: 1704–1713. https://www.nejm.org/doi/full/10.1056/nejmoa1202865
    1. "United States ex rel Krahling and Wlochowski v. Merck & Co., Case No. 10-cv-4374." Keller Grover. April 27. https://www.kellergrover.com/cases/whistleblower-actions/active-cases-whistleblower-actions/united-states-ex-rel-krahling-and-wlochowski-v-merck-co/
    1. "United States v. Merck & Co., Civil Action 10-4374." Casetext, part of Thomson Reuters. July 27. https://casetext.com/case/united-states-v-merck-co
  407. Centers for Disease Control and Prevention. 2024. "Mumps Cases and Outbreaks." cdc.gov. February 9. https://www.cdc.gov/mumps/outbreaks.html
  408. Centers for Disease Control and Prevention. 2023. "Rubella in the U.S." cdc.gov. November 14. https://www.cdc.gov/rubella/about/in-the-us.html
  409. Centers for Disease Control and Prevention. 2023. "Rubella in the U.S." cdc.gov. November 14. https://www.cdc.gov/rubella/about/in-the-us.html
  410. Leung, Jessica, et al. 2022. "The Impact of Universal Varicella Vaccination on Herpes Zoster Incidence in the United States: Comparison of Birth Cohorts Preceding and Following Varicella Vaccination Program Launch." The Journal of Infectious Diseases 226 (Supplement_4): S470–S477. https://doi.org/10.1093/infdis/jiac255
  411. Centers for Disease Control and Prevention. 2023. "Shingles Burden and Trends." cdc.gov. May 10. https://www.cdc.gov/shingles/surveillance.html
  412. Goldman, G. S., and P. G. King. 2013. "Review of the United States Universal Varicella Vaccination Program: Herpes Zoster Incidence Rates, Cost-effectiveness, and Vaccine Efficacy Based Primarily on the Antelope Valley Varicella Active Surveillance Project Data." Vaccine 31 (13): 1680–1694. https://doi.org/10.1016/j.vaccine.2012.05.050
  413. Centers for Disease Control and Prevention. 2022. "U.S. Chickenpox Vaccination Program." cdc.gov. https://www.cdc.gov/chickenpox/vaccination-program-impact.html
  414. Centers for Disease Control and Prevention. 2022. "Viral Hepatitis Surveillance: Number of reported cases of hepatitis A virus infection and estimated infections—United States, 2013–2020." cdc.gov. https://www.cdc.gov/hepatitis/statistics/2020surveillance/hepatitis-a/figure-1.1.htm
    1. "VAERS Data." Vaccine Adverse Event Reporting System (VAERS) on HHS.gov. https://vaers.hhs.gov/data.html
  416. GlaxoSmithKline (GSK). 1995. "Package Insert: HAVRIX (Hepatitis A Vaccine) injectable suspension, for intramuscular use." fda.gov. https://www.fda.gov/media/119388/download
  417. Merck & Co., Inc. 1996. "Package Insert: VAQTA® (Hepatitis A Vaccine, Inactivated)." fda.gov. https://www.fda.gov/media/74519/download
    1. "Cancer Stat Facts: Cervical Cancer." National Cancer Institute: Surveillance, Epidemiology, and End Results Program. https://seer.cancer.gov/statfacts/html/cervix.html
  419. American Cancer Society. 2024. Key Statistics for Cervical Cancer. January 17. https://www.cancer.org/cancer/types/cervical-cancer/about/key-statistics.html
  420. American Cancer Society. 2018. Cancer Statistics Center. https://cancerstatisticscenter.cancer.org/
  421. Tomljenovic, Lucija, Jean Pierre Spinosa, and Christopher A. Shaw. 2013. "Human Papillomavirus (HPV) Vaccines as an Option for Preventing Cervical Malignancies: (How) Effective and Safe?" Current Pharmaceutical Design 19 (8): 1466–1487. https://pubmed.ncbi.nlm.nih.gov/23016780/
    1. "NVIC Search Results From the 2/23/2024 Release of VAERS Data: Found 44,793 Adverse Event Cases Where Vaccine is IPV." MedAlerts.org. February 23. https://medalerts.org/vaersdb/findfield.php?TABLE=ON&GROUP1=CAT&GROUP2=SER&GRAPH=ON&GROUP6=CAT&EVENTS=ON&VAX=IPV
    1. "Human Papillomavirus (HPV) & HPV Vaccine Quick Facts." National Vaccine Information Center (NVIC). February 22. https://www.nvic.org/disease-vaccine/hpv/quick-facts
  424. Tomljenovic, Lucija, Jean Pierre Spinosa, and Christopher A. Shaw. 2013. "Human Papillomavirus (HPV) (FDA 2007) Vaccines as an Option for Preventing Cervical Malignancies: (How) Effective and Safe?" Current Pharmaceutical Design 19 (8): 1466–1487. https://pubmed.ncbi.nlm.nih.gov/23016780/
  425. Colafrancesco, Serena, Carlo Perricone, Lucija Tomljenovic, and Yehuda Shoenfeld. 2013. "Human Papilloma Virus Vaccine and Primary Ovarian Failure: Another Facet of the Autoimmune/Inflammatory Syndrome Induced by Adjuvants." American Journal of Reproductive Immunology 70 (4): 309–316. https://doi.org/10.1111/aji.12151
  426. Little, Deirdre Therese, and Harvey Rodrick Grenville Ward. 2014. "Adolescent Premature Ovarian Insufficiency following Human Papillomavirus Vaccination: A Case Series Seen in General Practice." Journal of Investigative Medicine High Impact Case Reports 2 (4). https://doi.org/10.1177%2F2324709614556129
  427. Tatang, Collins, Teigna Arredondo Bisonó, Aurore Bergamasco, et al. 2021. "Human Papillomavirus Vaccination and Premature Ovarian Failure: A Disproportionality Analysis Using the Vaccine Adverse Event Reporting System." Drugs—Real World Outcomes 9: 79–90. https://doi.org/10.1007/s40801-021-00271-6
  428. Merck & Co., Inc. 2014. "Package Insert: GARDASIL®9 (Human Papillomavirus 9-valent Vaccine, Recombinant)." fda.gov. https://www.fda.gov/media/90064/download
  429. Merck & Co., Inc. 2015. "Package Insert: GARDASIL® [Human Papillomavirus Quadrivalent (Types 6, 11, 16, and 18) Vaccine, Recombinant]." fda.gov. April. https://www.fda.gov/files/vaccines,%20blood%20&%20biologics/published/Package-Insert---Gardasil.pdf
  430. Merck & Co., Inc. 2015. "Package Insert: GARDASIL® [Human Papillomavirus Quadrivalent (Types 6, 11, 16, and 18) Vaccine, Recombinant]." fda.gov. April. https://www.fda.gov/files/vaccines,%20blood%20&%20biologics/published/Package-Insert---Gardasil.pdf
  431. Merck & Co., Inc. 2014. "Package Insert: GARDASIL®9 (Human Papillomavirus 9-valent Vaccine, Recombinant)." fda.gov. https://www.fda.gov/media/90064/download
  432. Merck & Co., Inc. 2014. "Package Insert: GARDASIL®9 (Human Papillomavirus 9-valent Vaccine, Recombinant)." fda.gov. https://www.fda.gov/media/90064/download
  433. Hooker, Brian S. 2014. "Measles-Mumps-Rubella Vaccination Timing and Autism among Young African American Boys: A Reanalysis of CDC Data." Translational Neurodegeneration 3 (16). https://doi.org/10.1186/2047-9158-3-16
  434. Attkisson, Sharyl. 2009. "Gardasil Researcher Speaks Out." CBS News Interactive Inc., August 19. https://www.cbsnews.com/news/gardasil-researcher-speaks-out/
  435. Health Impact News Editor. 2014. "Merck's Former Doctor Predicts That Gardasil Will become the Greatest Medical Scandal of All Time." Health Impact News, April 15. https://healthimpactnews.com/2014/mercks-former-doctor-predicts-that-gardasil-will-become-the-greatest-medical-scandal-of-all-time/
  436. Centers for Disease Control and Prevention. 2021. "Chapter 14: Meningococcal Disease Surveillance." In Epidemiology and Prevention of Vaccine-Preventable Diseases 14th ed. (The Pink Book), edited by Penina Haber and Sarah Schillie. Washington, D.C.: Public Health Foundation. https://www.cdc.gov/vaccines/pubs/pinkbook/mening.html
  437. Centers for Disease Control and Prevention. 2023. Meningococcal surveillance. cdc.gov via archive.org. October 23. https://web.archive.org/web/20231023215117/https://www.cdc.gov/meningococcal/surveillance/
  438. Kennedy Jr., Robert F. 2015. "Robert F. Kennedy, Jr.: Doing the Math on Meningitis Vaccinations." Daily Camera, June 9. https://www.dailycamera.com/2015/06/09/robert-f-kennedy-jr-doing-the-math-on-meningitis-vaccinations/
  439. ABC News. 2008. "Vaccines Seek to Offer Cradle-to-Grave Protection." ABC News, August 29. https://abcnews.go.com/Health/Healthday/story?id=5689652&page=1
  440. O'Toole, Zoey, and Mary Holland editors. 2022. "Chapter 1 Turtles All the Way Down: Vaccine Clinical Trials." Turtles All the Way Down: Vaccine Science and Myth, 35–84. The Turtles Team.
  441. Barberis, I., P. Myles, S. K. Ault, et al. 2016. "History and Evolution of Influenza Control through Vaccination: From the First Monovalent Vaccine to Universal Vaccines." Journal of Preventive Medicine and Hygiene 57 (3): E115–E120. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5139605/
  442. FDA. 2007. "FluMist Prior Approval Supplemental BLA." fda.gov. April. https://www.fda.gov/ohrms/dockets/ac/07/briefing/2007-4292B1-02.pdf
  443. Falsey, Ann R., John J. Treanor, Nadia Tornieporth, et al. 2009. "Randomized, Double-Blind Controlled Phase 3 Trial Comparing the Immunogenicity of High-Dose and Standard-Dose Influenza Vaccine in Adults 65 Years of Age and Older." The Journal of Infectious Diseases 200 (2): 172–180. https://doi.org/10.1086/599790
  444. FLCCC Alliance. 2023. "I-PREVENT COVID, Flu and RSV Protection Protocol." FLCCC Alliance. December 1. https://covid19criticalcare.com/protocol/i-prevent-covid-flu-rsv/
  445. Centers for Disease Control and Prevention. 1996. "Chapter 16: Tetanus." In Manual for the Surveillance of Vaccine-Preventable Diseases, by Amy Blain and Tejpratap S. P. Tiwari. Atlanta, GA: National Center for Immunization and Respiratory Diseases. https://www.cdc.gov/vaccines/pubs/surv-manual/chpt16-tetanus.html
  446. Tomljenovic, Lucija. 2011. "Aluminum and Alzheimer's Disease: After a Century of Controversy, Is There a Plausible Link?" Journal of Alzheimer's Disease 23 (4): 567–598. https://doi.org/10.3233/JAD-2010-101494
  447. Centers for Disease Control and Prevention. 2019. "Influenza (Flu): How CDC Estimates the Burden of Seasonal Influenza in the U.S." cdc.gov. November 22. https://www.cdc.gov/flu/about/burden/how-cdc-estimates.htm
  448. Centers for Disease Control and Prevention. 2024. "Influenza (Flu): Past Seasons Estimated Influenza Disease Burden." cdc.gov. February 28. https://www.cdc.gov/flu/about/burden/past-seasons.html
  449. Centers for Disease Control and Prevention. 2024. "RSV Fact Sheet Older Adults." cdc.gov. April. https://www.cdc.gov/rsv/factsheet-older-adults.pdf
  450. GlaxoSmithKline (GSK). 2023. "Package Insert: AREXVY (Respiratory Syncytial Virus Vaccine, Adjuvanted) suspension for intramuscular injection." fda.gov. May. https://www.fda.gov/media/167805/download
  451. GlaxoSmithKline (GSK). 2023. "Package Insert: AREXVY (Respiratory Syncytial Virus Vaccine, Adjuvanted) suspension for intramuscular injection." fda.gov. May. https://www.fda.gov/media/167805/download
  452. GlaxoSmithKline (GSK). 2023. "Package Insert: AREXVY (Respiratory Syncytial Virus Vaccine, Adjuvanted) suspension for intramuscular injection." fda.gov. May. https://www.fda.gov/media/167805/download
  453. GlaxoSmithKline (GSK). 2023. "Package Insert: AREXVY (Respiratory Syncytial Virus Vaccine, Adjuvanted) suspension for intramuscular injection." fda.gov. May. https://www.fda.gov/media/167805/download
  454. Pfizer. 2024. "Package Insert: ABRYSVO (Respiratory Syncytial Virus Vaccine) for injection, for intramuscular use." fda.gov. March. https://www.fda.gov/media/168889/download
  455. Pfizer. 2024. "Package Insert: ABRYSVO (Respiratory Syncytial Virus Vaccine) for injection, for intramuscular use." fda.gov. March. https://www.fda.gov/media/168889/download
  456. Havers, Fiona P., Michael Whitaker, Michael Melgar, et al. 2023. "Characteristics and Outcomes Among Adults Aged ≥60 Years Hospitalized with Laboratory-Confirmed Respiratory Syncytial Virus—RSV-NET, 12 States, July 2022–June 2023." MMWR: Recommendations and Reports 72 (40): 1075–1082. https://www.cdc.gov/mmwr/volumes/72/wr/mm7240a1.htm
  457. Centers for Disease Control and Prevention. 2023. "Shingles Burden and Trends." cdc.gov. May 10. https://www.cdc.gov/shingles/surveillance.html
  458. Altukhaim, Feras, May Mutlaq, Mohammed Alghamdi, and Salha Hakami. 2023. "Reactivation of Herpes Zoster After Recombinant Vaccine (Shingrix): A Case Report." Cureus 15 (1). https://doi.org/10.7759/cureus.34431
  459. GlaxoSmithKline (GSK). 2023. "Package Insert: SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted), suspension for intramuscular injection." fda.gov. May. https://www.fda.gov/media/108597/download
  460. Scutti, Susan. 2019. "Shingles Vaccine Side Effects Mostly Mild, Yet 3% of Complaints Were Serious, CDC Says." CNN Digital, January 31. https://www.cnn.com/2019/01/31/health/shingrix-shingles-vaccine-side-effects-report-cdc/index.html
  461. GlaxoSmithKline (GSK). 2023. "Package Insert: SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted), suspension for intramuscular injection." fda.gov. May. https://www.fda.gov/media/108597/download
  462. Marin, Mona, Amy Parker Fiebelkorn, Daoling Bi, et al. 2021. "Adverse Events among Young Adults following a Third Dose of Measles-Mumps-Rubella Vaccine." Clinical Infectious Diseases 73 (7): e1546–e1553. https://doi.org/10.1093/cid/ciaa1090
  463. Alonge, Oluwakemi D., Mona Marin, Carole J. Hickman, et al. 2024. "Long-term Neutralizing Antibody Levels against Measles and Rubella Viruses among Adults with 3 Doses of Measles-Mumps-Rubella Vaccine." Open Forum Infectious Diseases 11 (1). https://doi.org/10.1093/ofid/ofad700
  464. Kaaijk, Patricia, Alienke J. Wijmenga-Monsuur, Hinke I. ten Hulscher, et al. 2022. "Antibody Levels at 3-Years Follow-Up of a Third Dose of Measles-Mumps-Rubella Vaccine in Young Adults." Vaccines 10 (1): 132. https://doi.org/10.3390/vaccines10010132
  465. Fiebelkorn, Amy Parker, Laura A. Coleman, Edward A. Belongia, et al. Fall 2014. "Mumps Antibody Response in Young Adults After a Third Dose of Measles-Mumps-Rubella Vaccine." Open Forum Infectious Diseases 1 (3). https://doi.org/10.1093/ofid/ofu094
  466. Diep, Francie. 2014. "100 Years of Smoking Studies in Popular Science." Popular Science, January 10. https://www.popsci.com/article/science/100-years-smoking-studies-popular-science/
    1. "The 5 Ways Tobacco Companies Lied About the Dangers of Smoking Cigarettes." Truth Initiative. December 21. https://truthinitiative.org/research-resources/tobacco-prevention-efforts/5-ways-tobacco-companies-lied-about-dangers-smoking
  468. History.com Editors. 2009. "President Nixon signs legislation banning cigarette ads on TV and radio." History.com. https://www.history.com/this-day-in-history/nixon-signs-legislation-banning-cigarette-ads-on-tv-and-radio
    1. "List of Largest Pharmaceutical Settlements." Wikipedia. https://en.wikipedia.org/wiki/List_of_largest_pharmaceutical_settlements
  470. Pfizer. 2023. "Stories & News: A Record-Breaking Year and Strong Fourth Quarter for Pfizer." Pfizer Investor Insights. January 31. https://insights.pfizer.com/fourth-quarter-fy-earnings/
  471. Wakefield, Andrew J., S. H. Murch, A. Anthony, J. Linnell, D. M. Casson, M. Malik, M. Berelowitz, et al. 1998. "Ileal-lymphoid-nodular Hyperplasia, Non-specific Colitis, and Pervasive Developmental Disorder in Children." The Lancet 351 (9103): 637–641. https://doi.org/10.1016/S0140-6736(97)11096-0
  472. Walker, Stephen J., John Fortunato, Lenny G. Gonzalez, and Arthur Krigsman. 2013. "Identification of Unique Gene Expression Profile in Children with Regressive Autism Spectrum Disorder (ASD) and Ileocolitis." PLoS One 8 (3). https://doi.org/10.1371/journal.pone.0058058
  473. Lyons-Weiler, James, and Paul Thomas. 2020. "Relative Incidence of Office Visits and Cumulative Rates of Billed Diagnoses along the Axis of Vaccination." International Journal of Environmental Research and Public Health 17 (22): 8674. https://doi.org/10.3390/ijerph17228674
  474. Classen, John B., and David C. Classen. 2003. "Clustering of Cases of Type 1 Diabetes Mellitus Occurring 2–4 Years after Vaccination is Consistent with Clustering after Infections and Progression to Type 1 Diabetes Mellitus in Autoantibody Positive Individuals." Journal of Pediatric Endocrinology and Metabolism 16 (4): 495–508. https://pubmed.ncbi.nlm.nih.gov/12793601/
  475. DeStefano, Frank, Tanya Karapurkar Bhasin, William W. Thompson, Marshalyn Yeargin-Allsopp, and Coleen Boyle. 2004. "Age at First Measles-Mumps-Rubella Vaccination in Children with Autism and School-Matched Control Subjects: A Population-Based Study in Metropolitan Atlanta." Pediatrics 113 (2): 259–266. https://doi.org/10.1542/peds.113.2.259
  476. Mawson, Anthony R., Brian D. Ray, Azad R Bhuiyan, and Binu Jacob. 2017. "Pilot Comparative Study on the Health of Vaccinated and Unvaccinated 6- to 12-year-old U.S. Children." Journal of Translational Science 3 (3): 1–12. https://doi.org/10.15761/JTS.1000186
  477. Hooker, Brian S., and Neil Z. Miller. 2020. "Analysis of Health Outcomes in Vaccinated and Unvaccinated Children: Developmental Delays, Asthma, Ear Infections and Gastrointestinal Disorders." SAGE Open Medicine 8. https://doi.org/10.1177%2F2050312120925344
  478. Hooker, Brian S. 2014. "Measles-Mumps-Rubella Vaccination Timing and Autism among Young African American Boys: A Reanalysis of CDC Data." Translational Neurodegeneration 3 (16). https://doi.org/10.1186/2047-9158-3-16
  479. Aaby, Peter, Henrik Jensen, et al. 2004. "The Introduction of Diphtheria-Tetanus-Pertussis Vaccine and Child Mortality in Rural Guinea-Bissau: An Observational Study." International Journal of Epidemiology 33 (2): 374–380. https://academic.oup.com/ije/article/33/2/374/715842
  480. Kennedy Jr., Robert F., and Brian Hooker. 2023. Vax-Unvax: Let the Science Speak. Skyhorse Publishing.
  481. Aaby, Peter, Henrik Ravn, Adam Roth, et al. 2012. "Early Diphtheria-Tetanus-Pertussis Vaccination Associated with Higher Female Mortality and No Difference in Male Mortality in a Cohort of Low Birthweight Children: An Observational Study within a Randomised Trial." Archives of Disease in Childhood 97 (8): 685–691. https://adc.bmj.com/content/97/8/685
  482. Kennedy Jr., Robert F., and Brian Hooker. 2023. Vax-Unvax: Let the Science Speak. Skyhorse Publishing.
  483. Mogensen, Søren Wengel, Andreas Andersen, et al. 2017. "The Introduction of Diphtheria-Tetanus-Pertussis and Oral Polio Vaccine among Young Infants in an Urban African Community: A Natural Experiment." EBioMedicine 17: 192–198. https://doi.org/10.1016/j.ebiom.2017.01.041
  484. Geier, David A., Janet K. Kern, and Mark R. Geier. 2019. "A Cross-sectional Study of the Relationship Between Reported Human Papillomavirus Vaccine Exposure and the Incidence of Reported Asthma in the United States." SAGE Open Medicine 7. https://doi.org/10.1177/2050312118822650
  485. Mawson, Anthony R., Brian D. Ray, Azad R Bhuiyan, and Binu Jacob. 2017. "Pilot Comparative Study on the Health of Vaccinated and Unvaccinated 6- to 12-year-old U.S. Children." Journal of Translational Science 3 (3): 1–12. https://doi.org/10.15761/JTS.1000186
  486. Lyons-Weiler, James, and Paul Thomas. 2020. "Relative Incidence of Office Visits and Cumulative Rates of Billed Diagnoses Along the Axis of Vaccination." International Journal of Environmental Research and Public Health 17 (22): 8674. https://doi.org/10.3390/ijerph17228674
  487. Lyons-Weiler, James, and Russell L. Blaylock. 2022. "Revisiting Excess Diagnoses of Illnesses and Conditions in Children Whose Parents Provided Informed Permission to Vaccinate Them." International Journal of Vaccine Theory, Practice, and Research 2 (2): 603–618. http://dx.doi.org/10.56098/ijvtpr.v2i2.59
  488. Thomas MD, Paul, and Jennifer Margulis PhD. 2016. The Vaccine-Friendly Plan: Dr. Paul's Safe and Effective Approach to Immunity and Health—From Pregnancy Through Your Child's Teen Years. New York: Ballantine Books.
  489. Lyons-Weiler, James, and Paul Thomas. 2020. "Relative Incidence of Office Visits and Cumulative Rates of Billed Diagnoses along the Axis of Vaccination." International Journal of Environmental Research and Public Health 17 (22): 8674. https://doi.org/10.3390/ijerph17228674
  490. Cao, Zheng, Xu Yang, Haiyang Zhang, Haoran Wang, Wanyue Huang, Feibo Xu, Cuicui Zhuang, Xiaoguang Wang, and Yanfei Li. 2016. "Aluminum Chloride Induces Neuroinflammation, Loss of Neuronal Dendritic Spine and Cognition Impairment in Developing Rat." Chemosphere 151: 289–295. https://www.sciencedirect.com/science/article/abs/pii/S0045653516302533
  491. Choi, Gloria B., Yeong S. Yim, Helen Wong, Sangdoo Kim, et al. 2016. "The Maternal Interleukin-17a Pathway in Mice Promotes Autism-like Phenotypes in Offspring." Science 351 (6276): 933–939. https://www.science.org/doi/10.1126/science.aad0314
  492. Al-Ayadhi, Laila Yousef, and Gehan Ahmed Mostafa. 2012. "Elevated Serum Levels of Interleukin-17A in Children with Autism." Journal of Neuroinflammation 9 (158). https://jneuroinflammation.biomedcentral.com/articles/10.1186/1742-2094-9-158
  493. Akintunde, Marjannie Eloi, Melissa Rose, Paula Krakowiak, Luke Heuer, Paul Ashwood, Robin H. Hansen, Irva Hertz-Picciotto, and Judy Van de Water. 2015. "Increased Production of IL-17 in Children with Autism Spectrum Disorders and Co-morbid Asthma." Journal of Neuroimmunology 286: 33–41. https://www.jni-journal.com/article/S0165-5728(15)30004-7/abstract
  494. Ogura, Hideki, et al. 2013. "The Gateway Theory: How Regional Neural Activation Creates a Gateway for Immune Cells via an Inflammation Amplifier." Journal of Biomedical Science 36 (6). https://doi.org/10.4103/2319-4170.113187
  495. Hooker, Brian S., and Neil Z. Miller. 2020. "Analysis of Health Outcomes in Vaccinated and Unvaccinated Children: Developmental Delays, Asthma, Ear Infections and Gastrointestinal Disorders." SAGE Open Medicine 8. https://doi.org/10.1177%2F2050312120925344
  496. Hooker, Brian S., and Neil Z. Miller. 2021. "Health Effects in Vaccinated Versus Unvaccinated Children, with Covariates for Breastfeeding Status and Type of Birth." Journal of Translational Science 7 (1–11). https://www.oatext.com/pdf/JTS-7-459.pdf
  497. Kennedy Jr., Robert F., and Brian Hooker. 2023. Vax-Unvax: Let the Science Speak. Skyhorse Publishing.
  498. Blaylock, R. L., and Joseph Maroon. 2012. "Natural Plant Products and Extracts That Reduce Immunoexcitotoxicity-Associated Neurodegeneration and Promote Repair within the Central Nervous System." Surgical Neurology International 3: 19. https://pubmed.ncbi.nlm.nih.gov/22439110/
  499. Shoenfeld, Yehuda, Nancy Agmon-Levin, and Lucija Tomljenovic. 2015. Vaccines and Autoimmunity. Wiley-Blackwell.
    1. "Blog Post: What Is the Mother Fucker (MTHFR) Mutation? MTHFR." One Percent with Francesca. July 3. https://onepercentnet.wordpress.com/2017/07/03/what-is-the-mother-fucker-mthfr-mutation-mthfr/
  501. Lynch ND, Ben. 2018. Dirty Genes: A Breakthrough Program to Treat the Root Cause of Illness and Optimize Your Health. 1st edition. HarperOne.
  502. Centers for Disease Control and Prevention. 2024. "Traveler's Health." cdc.gov. https://wwwnc.cdc.gov/travel
  503. American Academy of Allergy Asthma & Immunology (AAAAI). 2020. Immunosuppressive Medication for the Treatment of Autoimmune Disease. September 28. https://www.aaaai.org/conditions-treatments/related-conditions/immunosuppressive
    1. "Judicial Notice: Numerical Risk Comparison of Non-vaccination Versus Vaccination." vaxcheckers.org. September. https://vaxcheckers.org/wp-content/uploads/2021/09/PRJN4.pdf

Follow:
Share with your Friends & Family
​* Doctor Paul & DeeDee Hoover do not diagnose nor treat any medical condition. We may provide information but always check with your trusted healthcare provider before using any information you may get from us or any of the resources we provide.
​** ​The contents of this site are for informational purposes only and are not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health care provider with any questions you have regarding a medical condition, and before undertaking any diet, dietary supplement, exercise, or other health program.

TOS

Site powered by MediaCor